Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2008 Annual Meeting | Poster Session 07

Thursday 04/17/08
11:30 AM - 02:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Headache/Other Pain Syndromes, Headache, Cerebrovascular Disease and Interventional Neurology, Critical Care/Emergency Neurology/Trauma, Neurotoxicology, Peripheral Nerve, Autonomic Disorders, MS and Related Diseases, Movement Disorders
No CME available
Event Timeline
11:30 AM - 02:30 PM Abstract 001 - A Comparative ID Migraine Screener Study in Ophthalmology, ENT, and Neurology Outpatient Clinics
11:30 AM - 02:30 PM Abstract 002 - Migraine with Neurologic Symptoms in Children: Is an Extensive Evaluation Needed?
11:30 AM - 02:30 PM Abstract 003 - Hypnic Headache: A French Prospective Clinical Descriptive Study
11:30 AM - 02:30 PM Abstract 004 - Acute Confusional Episodes Associated with Migraine May Be the Presenting Feature of CADASIL
11:30 AM - 02:30 PM Abstract 005 - Arachnoid Cysts in Children with Headache
11:30 AM - 02:30 PM Abstract 006 - Frontal Function Impairment in Patients with Chronic Daily Headache and Analgesic Overuse
11:30 AM - 02:30 PM Abstract 007 - Economic Burden of Transformed Migraine (TM): Results from the American Migraine Prevalence and Prevention (AMPP) Study
11:30 AM - 02:30 PM Abstract 008 - A Comparison of the Comorbid Disorders of Subjects with New Daily Persistent Headache and Transformed Migraine Suggests Similar Underlying Physiology
11:30 AM - 02:30 PM Abstract 009 - New Daily Persistent Headache: A New Venous Disease?
11:30 AM - 02:30 PM Abstract 010 - Doxycycline for Treatment Resistant New Daily Persistent Headache
11:30 AM - 02:30 PM Abstract 011 - A Comparison of Clinical Features of Subjects with New Daily Persistent Headache and Transformed Migraine Suggests Similar Underlying Pathophysiology
11:30 AM - 02:30 PM Abstract 013 - Personality Profile and Allodynic Migraine
11:30 AM - 02:30 PM Abstract 014 - Transformed Migraine with Medication Overuse That Needs Impatient Treatment: Experience in 46 Patients
11:30 AM - 02:30 PM Abstract 015 - Psychopathology and Quality of Life in Medication Overuse Headache: Differences between Patients Reporting Migraine or Tension Type Headache
11:30 AM - 02:30 PM Abstract 016 - White Matter Abnormalities in Migraine and Tension-Type Headache
11:30 AM - 02:30 PM Abstract 018 - Oligomerization State-Dependent Elevations of the Adipocytokine, Adiponectin, in Chronic Daily Headache
11:30 AM - 02:30 PM Abstract 019 - Activities of Cerebrospinal Fluid Enzymes That Metabolize Endocannabinoids Are Altered in Migraine
11:30 AM - 02:30 PM Abstract 020 - Migraine and Obesity - The Effect of Bariatric Surgery
11:30 AM - 02:30 PM Abstract 021 - Self-Reported Versus Measured Body Mass Indices in Migraineurs
11:30 AM - 02:30 PM Abstract 022 - Triptans Attenuate Capsaicin-Induced CREB Phosphorylation within the Trigeminal Nucleus Caudalis: A New Marker for Activated Trigeminal Neurons
11:30 AM - 02:30 PM Abstract 023 - Effect of Intranasal Delivery of Carbon Dioxide on Trigeminal Ganglion Neurons: Inhibition of Neuron-Glia Gap Junction Communication and SNAP-25 Expression
11:30 AM - 02:30 PM Abstract 024 - Comparisons between Heavily T2-Weighted MR and CT Myelography Studies in Two Patients with Spontaneous Intracranial Hypotension
11:30 AM - 02:30 PM Abstract 025 - Reversible Cerebral Vasoconstriction Syndrome: Report of a Case Treated Successfully with Intra-Arterial Milrinone
11:30 AM - 02:30 PM Abstract 026 - Reversible Cerebral Vasoconstriction Syndrome and Occipital Lobe Infarction after Triptan Use
11:30 AM - 02:30 PM Abstract 027 - Reversal of Coma from Spontaneous Intracranial Hypotension by Lumbar Epidural Blood Patch in Trendelnburg Position
11:30 AM - 02:30 PM Abstract 028 - Clinico-Pathological Study in Chronic Hypertrophic Pachymeningitis
11:30 AM - 02:30 PM Abstract 029 - Targeted Epidural Blood Patch with Computerized Tomography-Myelography in Spontaneous Intracranial Hypotension
11:30 AM - 02:30 PM Abstract 030 - Potential Reduction in Headache Rate and Cost of Care Following Lumbar Puncture at a Single Tertiary Care Hospital
11:30 AM - 02:30 PM Abstract 031 - Burden of Migraine Headache in Three U.S. Employers before and after an Employee Education Program
11:30 AM - 02:30 PM Abstract 032 - Final Analysis of the American Headache Society Objective Simulated Computer Encounters for Assessing the ACGME Competencies
11:30 AM - 02:30 PM Abstract 033 - What Are the Action Mechanisms of Lumbar Epidural Blood Patch in Trendelenburg Position in the Treatment of Spontaneous Cervical CSF Leakage?
11:30 AM - 02:30 PM Abstract 034 - Current Acute Migraine Treatment Patterns: How Prevalent Is Early Intervention and Multiple Medication Use?
11:30 AM - 02:30 PM Abstract 035 - Evaluation of Combination Therapy (Sumatriptan/Naproxen Sodium) Versus Monotherapy for the Acute Treatment of Migraine Using a Novel Clinical Endpoint: Sustained Pain Free and No Adverse Events
11:30 AM - 02:30 PM Abstract 036 - A Sub-Study To Evaluate the Role of Prostaglandins in Women with Menstrual Migraine and Dysmenorrhea and the Effect of Sumatriptan/Naproxen Sodium (SumaRT/Nap) When Administered during the Mild Pain Phase
11:30 AM - 02:30 PM Abstract 037 - Incidence of Migraine across the Menstrual Cycle in Women with Difficult-to-Treat Menstrual Migraine
11:30 AM - 02:30 PM Abstract 038 - Assessing the Relationship of Functioning to Pain Endpoints in Migraine Sufferers Treated with a Single-Tablet of Sumatriptan RT[trade] and Naproxen Sodium (SumaRT/Nap) Versus Placebo
11:30 AM - 02:30 PM Abstract 039 - Intranasal Sumatriptan Powder Delivered with a New Device Is as Effective as 6 mg SC Sumatriptan in Preventing GTN Challenge Induced EEG Changes in Migraineurs
11:30 AM - 02:30 PM Abstract 041 - Sustained Pain Relief in Migraine Is Not Necessarily Dependent on the PK of a Drug and Does Not Have To Be at the Cost of Rapid Onset of Relief
11:30 AM - 02:30 PM Abstract 042 - Relief of Menstrual Symptoms and Migraine after Early Treatment with a Fixed Single-Tablet Formulation of Sumatriptan with RT Technology[trade] and Naproxen Sodium (SumaRT/Nap)
11:30 AM - 02:30 PM Abstract 043 - Partial Versus Full Dose Intravenous Recombinant Tissue Plasminogen Activator Followed by Intra-Arterial Thrombolytic Therapy for Acute Ischemic Stroke
11:30 AM - 02:30 PM Abstract 044 - How Often Do Patients with Positive Xanthochromia and Normal CT Have a Ruptured Aneurysm?
11:30 AM - 02:30 PM Abstract 045 - Long-Term Outcome after Intravenous Thrombolysis in Vertebrobasilar Ischemic Stroke without Occlusion of the Basilar Artery
11:30 AM - 02:30 PM Abstract 047 - Effects of NIHSS Score Errors on Accuracy of Prediction in rtPA Treated Stroke Patients: A Simulation Study
11:30 AM - 02:30 PM Abstract 048 - Magnetically-Guided In Vivo Thrombolysis with tPA-Loaded Nanocarriers
11:30 AM - 02:30 PM Abstract 049 - Comparison of Outcome of Patients Treated with IV TPA in a Drip and Ship Model in Rural Hospitals Initially Triaged by Neurologists vs. Stroke Neurologists
11:30 AM - 02:30 PM Abstract 050 - Prediction of Outcome in rtPA Treated Stroke Patients: Comparison of Logistic Regression and Classification and Regression Trees Models
11:30 AM - 02:30 PM Abstract 051 - Multimodal Interventional Approach to Acute Ischemic Stroke: A Cleveland Clinic Experience
11:30 AM - 02:30 PM Abstract 052 - Identification of Stroke Mimics in the Emergency Department Setting
11:30 AM - 02:30 PM Abstract 053 - Is There a Role for CT-Angiography in the Initial Evaluation of Acute Stroke Patients?
11:30 AM - 02:30 PM Abstract 054 - Validation of Korean Version of the FOUR Score
11:30 AM - 02:30 PM Abstract 055 - The Effect of Mechanical Disruption of Thrombus during Intra-Arterial Thrombolysis for Patients with Acute Ischemic Stroke
11:30 AM - 02:30 PM Abstract 056 - Warfarin Use and Symptomatic Intracranial Hemorrhage Following Intravenous Tissue Plasminogen Activator for Ischemic Stroke: A Single Center Experience
11:30 AM - 02:30 PM Abstract 057 - Beta-Trace Protein as a Marker for Cerebrospinal Fluid Leakage
11:30 AM - 02:30 PM Abstract 058 - Is Early Arrival to the Hospital after Symptom Onset Associated with Better 3 Month Outcomes in Patients Not Treated with Thromboytics?
11:30 AM - 02:30 PM Abstract 059 - Prevalence of Elevated Blood Pressure in Adult Patients Presenting to the Emergency Department in the United States
11:30 AM - 02:30 PM Abstract 060 - Targeting of Cell Death In Vivo in Experimental Traumatic Brain Injury by a Novel Molecular Probe
11:30 AM - 02:30 PM Abstract 061 - Review of Phenytoin and Levetiracetam Use in the Neurological Intensive Care Unit at Loyola University Medical Center
11:30 AM - 02:30 PM Abstract 062 - Superselective Intra-Arterial Magnesium for the Treatment of Arterial Vasospasm in Patients with Subarachnoid Hemorrhage
11:30 AM - 02:30 PM Abstract 063 - Sporadic Creutzfeldt-Jakob Disease Revealed by Pseudostatus Epilepticus: A Study of 10 Patients
11:30 AM - 02:30 PM Abstract 065 - CLEAR IVH: A Comparison of CSF Disposition of Two Different Dosing Regimens of Intraventricular rt-PA
11:30 AM - 02:30 PM Abstract 066 - Fulminant Guillian-Barre Syndrome Mimicking Cerebral Death: Case Reports and Literature Review
11:30 AM - 02:30 PM Abstract 067 - Intracerebral Hemorrhage - Predictors of Withdrawal of Care
11:30 AM - 02:30 PM Abstract 068 - BEST "Better Early Stroke Treatment": Implementation of Nursing Questionnaire Aids in Triage of Acute Ischemic Stroke Patients
11:30 AM - 02:30 PM Abstract 069 - Complications of Large Volume Plasmapheresis in Neurological Disorders - An Indian Scenario
11:30 AM - 02:30 PM Abstract 070 - Diffusion-Weighted MR Imaging in Closed Head Injury: Identification of Distinct Injury Subtypes and Correlation with Functional Outcome
11:30 AM - 02:30 PM Abstract 071 - 2T or Not 2T? Advantages of a New Coma Scale (FOUR Score) over the Glasgow Coma Scale
11:30 AM - 02:30 PM Abstract 072 - Prognostic Value of Transcranial Doppler Ultrasound in the Early Phase of Aneurysmal Subarachnoid Hemorrhage
11:30 AM - 02:30 PM Abstract 073 - Fever Is an Acute Neurotoxin after Subarachnoid Hemorrhage
11:30 AM - 02:30 PM Abstract 074 - Intracranial Hemorrhage - Predictors of Outcome in a Closed Versus Semi-Closed Neurointensive Care Unit
11:30 AM - 02:30 PM Abstract 075 - Subtypes of Traumatic Brain Injury: Correlation of CT Features with Clinical Phenotypes
11:30 AM - 02:30 PM Abstract 076 - Prolonged EEG Monitoring in Comatose Patients: When We Should Stop
11:30 AM - 02:30 PM Abstract 077 - Small Fiber Neuropathy Following Vaccination for Rabies or Lyme Disease
11:30 AM - 02:30 PM Abstract 078 - Bulbar Neuronopathy and Baroreflex Failure as Late Sequelae of Neck Irradiation
11:30 AM - 02:30 PM Abstract 079 - A Case-Series of Extra and Central Pontine Myelinolysis (n=12): Lessons from a Heterogeneous Disorder
11:30 AM - 02:30 PM Abstract 080 - Diffusion-Weighted MR Imaging Findings in Wernicke's Encephalopathy
11:30 AM - 02:30 PM Abstract 081 - Cervical Myelopathy Following Injections into the Neck: Report of Three Cases
11:30 AM - 02:30 PM Abstract 082 - An Unusual Cause of Visual Loss
11:30 AM - 02:30 PM Abstract 083 - CNS Vasculitis as a Manifestation of Systemic Sclerosis
11:30 AM - 02:30 PM Abstract 084 - Oral Methotrexate in Multifocal Motor Neuropathy Patients Treated with IVIg
11:30 AM - 02:30 PM Abstract 085 - Multifocal Motor Neuropathy, a Population-Based Study in The Netherlands
11:30 AM - 02:30 PM Abstract 086 - Anti-Ganglioside Autoantibodies Profiling in Patients with Autoimmune Peripheral Neuropathies by a New Line Immunoassay
11:30 AM - 02:30 PM Abstract 087 - Chronic Demyelinating Polyneuropathy Associated with IgM Monoclonal Gammopathy without Anti-MAG Antibodies: Clinical, Electrophysiological and Laboratory Findings in 18 Cases
11:30 AM - 02:30 PM Abstract 088 - Long Term Outcome and Prognostic Factors of Polyneuropathy Associated with IgM Monoclonal Gammopathy
11:30 AM - 02:30 PM Abstract 089 - Beneficial Effects of Rituxmab in Patients with Anti-MAG Neuropathy
11:30 AM - 02:30 PM Abstract 090 - New 10% Liquid Intravenous Immunoglobulin in Multifocal Motor Neuropathy: Prospective Study of Efficacy, Safety and Tolerability
11:30 AM - 02:30 PM Abstract 091 - Different Patterns of Cytokines Are Associated to Chronic Dysimmune Polyneuropathies
11:30 AM - 02:30 PM Abstract 092 - Peripheral Neuropathy in Newly Diagnosed Multiple Myeloma Patients
11:30 AM - 02:30 PM Abstract 093 - Long-Term Safety Profile of Immune Globulin Intravenous, 10% Caprylate/Chromatography Purified (IGIV-C; Gamunex[reg]) Therapy in the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
11:30 AM - 02:30 PM Abstract 094 - Peripheral Plasmacytosis Predicts Intravenous Immunoglobulin Efficacy in Patients with Guillain-Barr[eacute] Syndrome
11:30 AM - 02:30 PM Abstract 095 - Inside Guillain Barr[eacute] Syndrome (GBS) - The Personal Experience of a Patient Who Is a Consultant in Rehabilitation Medicine
11:30 AM - 02:30 PM Abstract 096 - Guillain-Barr[eacute] Syndrome in a Referral Center of Mexico: High Frequency of Hand-Weakness Onset, Axonal and Motor Variants
11:30 AM - 02:30 PM Abstract 097 - Nerve Conduction Studies (NCS) in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Treated with Intravenous Immunoglobulin Therapy Versus Placebo
11:30 AM - 02:30 PM Abstract 098 - Clinical Analysis of Chronic Inflammatory Demyelinating Polyradiculoneuropathy
11:30 AM - 02:30 PM Abstract 099 - FTY720 Halts the Progression of Spontaneous Autoimmune Polyneuropathy in B7-2 Deficient NOD Mice
11:30 AM - 02:30 PM Abstract 100 - CIDP with Minimal Change Disease: A Possible Clue to Determining Resistant Variants
11:30 AM - 02:30 PM Abstract 101 - Efficacy of Interferon Beta-1a in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
11:30 AM - 02:30 PM Abstract 102 - Sural Nerve Morphology and Morphometry in Aging Rats
11:30 AM - 02:30 PM Abstract 103 - Fatigue in Peripheral Neuropathy
11:30 AM - 02:30 PM Abstract 105 - Modulation of Baroroflex Sensitivity during Modified Oxford Manoeuvre - Application of the Trigonometric Regressive Analysis for Nonstationary Baroreflex Analysis
11:30 AM - 02:30 PM Abstract 106 - A Dynamic Analysis of Sudomotor Function Using QDIRT in a Human Model of Small Fiber Neuropathy
11:30 AM - 02:30 PM Abstract 107 - The Cutaneous Architecture of Autonomic Nerve Fiber Innervation
11:30 AM - 02:30 PM Abstract 108 - A Comparison of the Quantitative Sudomotor Reflex Test with Skin Biopsy in Diagnosing Small Fiber Neuropathy
11:30 AM - 02:30 PM Abstract 109 - Usefulness of Infrared Dynamic Pupillometry in the Diagnosis of Small Fiber Neuropathy
11:30 AM - 02:30 PM Abstract 110 - Pupil Reaction to Olfactory and Trigeminal Stimuli
11:30 AM - 02:30 PM Abstract 111 - Cold Face Test in the Assessment of Cardiovagal Function: Comparison with Other Tests
11:30 AM - 02:30 PM Abstract 112 - Clinical Evolution of the Somatic and Autonomic Neuropathy Induced by Chronic Intravenous Vincristine Administration in Awake Rats: A New Model of Autonomic Neuropathy
11:30 AM - 02:30 PM Abstract 113 - Right Middle Cerebral Artery Stroke Blunts Cardiovascular Responses to Music, Left Middle Cerebral Artery Stroke Reduces Blood Pressure Response to Pleasant Music
11:30 AM - 02:30 PM Abstract 114 - Correlation between Orthostatic Hypotension and Supine Hypertension in Autonomic Synucleinopathies
11:30 AM - 02:30 PM Abstract 115 - Sympathetic and Parasympathetic Abnormalities in the Early Stages of Peripheral Neuropathies
11:30 AM - 02:30 PM Abstract 116 - Asymmetric Dopamine Deficit Is Associated with Differential Patterns of Autonomic Nervous System Response to Mental Stress
11:30 AM - 02:30 PM Abstract 117 - Effects on Cardiovascular and Sympathetic Skin Regulation of Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) in Parkinson's Disease with and without Orthostatic Hypotension
11:30 AM - 02:30 PM Abstract 118 - Migrainous Dysautonomia - A Novel Cause of Hypertension in Post-Menopausal Women
11:30 AM - 02:30 PM Abstract 119 - Frequency of Syncope with Migrainous Features in a Population of Patients Referred for Autonomic Testing
11:30 AM - 02:30 PM Abstract 120 - Autonomic Neuropathy in Hepatitis C Virus (HCV) Infected Patients
11:30 AM - 02:30 PM Abstract 121 - Secondary Atrial Fibrillation Develop More Often after Rt MCA Infarct Than the Left Side
11:30 AM - 02:30 PM Abstract 122 - Elevated Titers of Anti-Thyroperoxidase Antibodies in Patients with Multiple System Atrophy
11:30 AM - 02:30 PM Abstract 123 - FTY720 Induces BDNF Production in Neuronal Cell Cultures
11:30 AM - 02:30 PM Abstract 124 - Dose- and Treatment Duration-Dependent Effects of FTY720 on Human Oligodendroglial Process Dynamics
11:30 AM - 02:30 PM Abstract 125 - Elevated Hematopoietic Stem/Progenitor Cell Counts Circulating in Patients with Multiple Sclerosis Treated with Natalizumab
11:30 AM - 02:30 PM Abstract 126 - The Val66Met BDNF Polymorphism in Multiple Sclerosis: Potential Biomarker for Treatment Response to Glatiramer Acetate
11:30 AM - 02:30 PM Abstract 127 - Laquinimod Reduces Level of IL-17 in Cultured Splenocytes from Treated MOG Induced Experimental Autoimmune Encephalomyelitis and in Cultured PBMCs from Healthy Human Donors
11:30 AM - 02:30 PM Abstract 128 - Possible Role of Adipocytokines in the Pathogenesis of Multiple Sclerosis: A Finnish Co-Twin Study
11:30 AM - 02:30 PM Abstract 129 - Increased PD-L1 Expression and Functional Deficiencies in Human Plasmacytoid Dendritic Cells
11:30 AM - 02:30 PM Abstract 130 - Interferon Beta-1a Modulates the Initiation of Autoimmune Response in Patients with Clinically Isolated Syndrome Suggestive of Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 131 - Primary Progressive MS Shows a Characteristic Cellular and Protein CSF Profile
11:30 AM - 02:30 PM Abstract 132 - Proteomic Characterization of Cerebrospinal Fluid and Genomic Characterization of Peripheral Blood Mononuclear Cells in Patients with Clinically Isolated Syndrome Suggestive of Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 133 - Nogo-A in Multiple Sclerosis Cerebrospinal Fluid
11:30 AM - 02:30 PM Abstract 134 - Laquinimod Induced Downregulation of MHC Class II Gene Expression in Cultured Peripheral Blood Cells of Untreated Patients with Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 135 - Unpaired Oligoclonal Bands Persist in the Cerebrospinal Fluid of Patients with Multiple Sclerosis Following Treatment with Alemtuzumab
11:30 AM - 02:30 PM Abstract 136 - Anti-CD25 Antibody Daclizumab In Vitro Greatly Enhances IL-2-Induced Expansion of CD56bright NK Cells
11:30 AM - 02:30 PM Abstract 137 - Comparison of the Immunomodulatory Effects of the Plant Sterol [beta]-Sitosterol to Simvastatin in Peripheral Blood Cells from Multiple Sclerosis Patients
11:30 AM - 02:30 PM Abstract 138 - Correlation between DJ-1 Levels in Cerebrospinal Fluid and Progression of Disability in Patients with Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 139 - Peripheral Blood Dendritic Cells Secrete Lower Levels of Pro-Inflammatory Cytokines in Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 140 - Proteasome Autoantibodies in Optic Neuritis May Predict Progression to Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 141 - A Novel Type of Proinflammatory Human Dendritic Cell (slan-DC) Is Present in Inflammatory CNS Disease and Can Be Modulated in a Different Way by Immunomodulatory Therapies
11:30 AM - 02:30 PM Abstract 142 - Effects of Glia-Derived Factors on Human B Cells: Implication to Multiple Sclerosis Pathogenesis
11:30 AM - 02:30 PM Abstract 143 - Gene Expression Patterns of Peripheral Blood Cells Subpopulations in Acute Optic Neuritis: The Role of CD19+ B Cells
11:30 AM - 02:30 PM Abstract 144 - Tears Analysis: A New Standard for Multiple Sclerosis Diagnosis
11:30 AM - 02:30 PM Abstract 145 - Quercetin and Interferon-[beta] Modulate Immune Response(s) in Multiple Sclerosis Patients: In Vitro Studies
11:30 AM - 02:30 PM Abstract 146 - Conformational Serum Anti-Myelin Antibodies Are Not Associated with Preclinical Phase of MS
11:30 AM - 02:30 PM Abstract 147 - CD45RA+ (Na[iuml]ve) T Helper Cell Percentages (NTHCP) Correlate with Measures Related to Cognitive Function in Patients with Multiple Sclerosis (MS)
11:30 AM - 02:30 PM Abstract 148 - Increased Intrathecal Chemokine Receptor CCR2 Expression in Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 149 - Time-Dependent RNA Signatures of Peripheral Blood Cells from Interferon Beta Treated MS Patients Disclose Consistent Differential Gene Expression
11:30 AM - 02:30 PM Abstract 150 - Multiple Sclerosis (MS) Patients Taking Interferon-beta-1a (IFNb1a) Have Full Biological Activity in Both Stable and Breakthrough Disease
11:30 AM - 02:30 PM Abstract 151 - Soluble Receptor for Advanced Glycation End Products in Multiple Sclerosis: A Potential Biomarker of Disease Severity
11:30 AM - 02:30 PM Abstract 152 - Modulation of IFNAR1 mRNA Expression in Multiple Sclerosis Patients
11:30 AM - 02:30 PM Abstract 153 - Antibodies to Epstein-Barr Virus Early Antigen Are Increased in Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 154 - Effect of Natalizumab on Regulatory T Cells: Analysis of Frequency, Migratory Behaviour and Suppressive Capacity of Two Natural Regulatory T Cell Populations In Vitro and Ex Vivo
11:30 AM - 02:30 PM Abstract 155 - Tau Protein Concentrations in Cerebrospinal Fluid of Patients with Multiple Sclerosis: Relationship with Disease Course and Activity
11:30 AM - 02:30 PM Abstract 156 - Type 1 Interferon Receptor (IFNA-R1) Expressing Th17 Lymphocytes Are Increased during MS Relapses and Are Selectively Inhibited by IFN[beta]
11:30 AM - 02:30 PM Abstract 157 - Altered Human Pancreatic Ribonuclease 1 in Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 158 - Comparison of 2 Year Whole Genome RNA Expression Profiles Derived from Peripheral Blood Reveals Evident Pharmacological Differences Due to Distinct Interferon-beta Therapies
11:30 AM - 02:30 PM Abstract 159 - Cytokine and Chemokine mRNA in Peripheral Blood of MS Patients Correlates with Treatment Response and Interferon Beta Dose
11:30 AM - 02:30 PM Abstract 160 - BaroFeron[trade], an Interferon Beta Product, with Improved Bioavailability
11:30 AM - 02:30 PM Abstract 161 - Functional Differences of Binding vs. Neutralizing Anti-Interferon Beta Antibodies in MS Patients - Assessment of IgG Isotypes, Titers and Affinities
11:30 AM - 02:30 PM Abstract 162 - CD454RA+ T Helper Cell Percentages Correlate with Measures Related to Cognitive Function in Patients with Multiple Sclerosis (MS)
11:30 AM - 02:30 PM Abstract 163 - Effect of Natalizumab on Counts and Function on Natural Regulatory T-Cells in Patients with Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 164 - Genes That Are Over-Expressed in Multiple Sclerosis Are Not Specifically Regulated by Treatment with Interferon-beta
11:30 AM - 02:30 PM Abstract 165 - Natalizumab in Multiple Sclerosis - Monitoring CD4:CD8 Ratios and JC Viral Loads
11:30 AM - 02:30 PM Abstract 166 - A Potential Blood Based Diagnostic Marker of Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 167 - How Are MS Relapses Treated?
11:30 AM - 02:30 PM Abstract 168 - Spontaneous MxA mRNA Expression in Multiple Sclerosis Is Associated with IL10 mRNA Expression and Low MRI Disease Activity
11:30 AM - 02:30 PM Abstract 169 - Blood Gene Signatures in Clinically Isolated Syndromes and Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 170 - Application of Disease-Related Metabolic Networks for Automated Differential Diagnosis of Parkinsonian Disorders
11:30 AM - 02:30 PM Abstract 171 - Nocturnal Sudden Death in Patients with Multiple System Atrophy
11:30 AM - 02:30 PM Abstract 172 - Comparison of 18F-FDG PET and Clinical Features of 50 Cases with Early Multiple System Atrophy: Different Patterns of Glucose Metabolism between Possible and Probable Subtype
11:30 AM - 02:30 PM Abstract 173 - The Wide Spectrum of Clinicopathological Manifestations in Pathologically Proven Progressive Supranuclear Palsy: A Study of Japanese Patients
11:30 AM - 02:30 PM Abstract 174 - Autonomic Dysfunction in Different Subtypes of Multiple System Atrophy (MSA): MSA-P vs. MSA-C
11:30 AM - 02:30 PM Abstract 175 - Brainstem Atrophy on Routine MR Study in Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17 (FTDP-17)
11:30 AM - 02:30 PM Abstract 176 - Neurodegenerative "Overlap" Syndrome: Parkinsonism, Motor Neuron Disease, and Cognitive Decline
11:30 AM - 02:30 PM Abstract 177 - Sporadic Guam Parkinsonian Complex or the Co-Incidence of Several Neurodegenerative Conditions: The Report of 4 Czech Cases Suffering from Parkinsonism, Amyotrophic Lateral Sclerosis and Dementia
11:30 AM - 02:30 PM Abstract 178 - High Prevalence of Cerebral Microbleeds in Vascular Parkinsonism
11:30 AM - 02:30 PM Abstract 179 - Comparison of Neuropsychological Profiles of Normal Pressure Hydrocephalus and Parkinson's Disease with Dementia
11:30 AM - 02:30 PM Abstract 180 - Fluoroscopic, EMG-Guided, Botulinum-Toxin Injection into the Longus Colli and Longus Capitis for the Treatment of Anterocollis
11:30 AM - 02:30 PM Abstract 181 - Does Previous Response to a Botulinum Toxin Type A Affect Subsequent Treatment with Botulinum Toxin Type B in Patients with Cervical Dystonia? Analysis of a Long-Term Open-Label Study (AN072-401 EU/CD)
11:30 AM - 02:30 PM Abstract 182 - Botulinum Toxin Type A (Botox) Versus Botulinum Toxin Type B (MYOBLOC) in Patients with Cervical Dystonia: A Comparison of the Frequency of Xerostomia and Dysphagia
11:30 AM - 02:30 PM Abstract 183 - Botulinum Toxin Type B Effects on Pain Associated with Cervical Dystonia: Results of a Meta-Analysis
11:30 AM - 02:30 PM Abstract 184 - Botulinum Toxin Type B in Cervical Dystonia: A Two-Year Open-Label Study in Botulinum Toxin Type A Resistant/Responsive Subjects (AN072-401 EU/CD)
11:30 AM - 02:30 PM Abstract 185 - Retrospective Analysis of Cervical Dystonia Patient Population and Treatment Patterns at Vanderbilt University
11:30 AM - 02:30 PM Abstract 186 - Involvement of the Human Pedunculopontine Nucleus Region in Movement Preparation
11:30 AM - 02:30 PM Abstract 187 - Treatment of Freezing of Gait in Parkinson's Disease with Deep Brain Stimulation of the Pedunculopontine Nucleus
11:30 AM - 02:30 PM Abstract 188 - Clinical Experience with Transdermal Patch of Rotigotine in Parkinson's Disease
11:30 AM - 02:30 PM Abstract 189 - A Single Dose, Placebo Controlled, Cross-Over Trial Comparing the Latency to Onset of Orally Disintegrating (OD) Levodopa (Parcopa) Verses Oral (PO) Levodopa
11:30 AM - 02:30 PM Abstract 190 - Transient Exacerbation of Cerebellar Ataxia by Smoking Cigarettes: A Prevalence Survey
11:30 AM - 02:30 PM Abstract 191 - Autosomal-Dominant Neurodegenerative Disorder with Predominantly Spinocerebellar Signs
11:30 AM - 02:30 PM Abstract 192 - Prevalence of Cardiac Abnormalities in Friedreich Ataxia
11:30 AM - 02:30 PM Abstract 193 - Gray and White Matter Atrophy Revealed by Voxel-Based Morphometry (VBM) in Machado-Joseph Disease
11:30 AM - 02:30 PM Abstract 194 - Spinocerebellar Ataxia 12 Found Only in Agarwal Ethnic Group in India
11:30 AM - 02:30 PM Abstract 195 - Psychogenic Tremor Outcomes
11:30 AM - 02:30 PM Abstract 196 - Characteristics of Archimedean Spiral Drawing in Patients with Psychogenic Tremor
11:30 AM - 02:30 PM Abstract 197 - Phenomenology of Psychogenic Movement Disorders in Children
11:30 AM - 02:30 PM Abstract 198 - Morbidity Associated with Psychogenic Movement Disorders in Children
11:30 AM - 02:30 PM Abstract 199 - Genetic Analysis of the Parkin Gene as a Modifier in Restless Legs Syndrome (RLS)
12:00 PM - 01:30 PM Break
Faculty Disclosures
Jeremy D. Schmahmann, MD, FAAN Dr. Schmahmann has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. The institution of Dr. Schmahmann has received research support from National Ataxia Foundation. The institution of Dr. Schmahmann has received research support from Biohaven. Dr. Schmahmann has received intellectual property interests from a discovery or technology relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care.
Roy L. Freeman, MD Dr. Freeman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cutaneous Diagnostic Life Sciences. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theravance. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Inhibikase. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Freeman has received research support from NIH. The institution of Dr. Freeman has received research support from Theravance. The institution of Dr. Freeman has received research support from Biohaven. The institution of Dr. Freeman has received research support from Lundbeck. Dr. Freeman has received research support from Regeneron.
Joseph Jankovic, MD, FAAN Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance, Allergan. The institution of Dr. Jankovic has received research support from Baylor College of Medicine. Dr. Jankovic has received research support from Abbvie. The institution of Dr. Jankovic has received research support from Abbvie.
William M. Coplin, MD, FCCM No disclosure on file
Steven Frucht, MD Dr. Frucht has nothing to disclose.
Ronald Schondorf, MD No disclosure on file
Peter D. Donofrio, MD, FAAN No disclosure on file
Horacio C. Kaufmann, MD, FAAN Dr. Kaufmann has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Theravance. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Kaufmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curasen Therapeutics. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AskBio. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BioArctic. Dr. Kaufmann has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Spinger. The institution of Dr. Kaufmann has received research support from Biogen. The institution of Dr. Kaufmann has received research support from Vaxxinity. Dr. Kaufmann has received publishing royalties from a publication relating to health care.
J. E. Ahlskog, MD, PhD Dr. Ahlskog has received publishing royalties from a publication relating to health care.
Thomas P. Bleck, MD, FAAN Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceuticals. Dr. Bleck has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for iECURE. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acasti. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Society of Critical Care Medicine. Dr. Bleck has received research support from NIH.
David W. Dodick, MD, FAAN Dr. Dodick has received personal compensation for serving as an employee of Mayo Clinic. Dr. Dodick has received personal compensation for serving as an employee of Atria Health. Dr. Dodick has received personal compensation for serving as an employee of Thomas Jefferson University . Dr. Dodick has received personal compensation for serving as an employee of Norwegian University of Science and Technology. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Allergan. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biopharm Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inside Practice Australia. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Education Alliance. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of the Pacific . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medica Communications. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJ Healthcare. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nocira. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vector Psychometrics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Ayya Biosciences. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Theranica. Dr. Dodick has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atria. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WebMD. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Thomas Jefferson University. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medforce. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision HEOR. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canadian Headache Society. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of New England. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Japan. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for KingDevick Technologies. Dr. Dodick has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Precon Health. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ontologics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Matterhorn. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Axon Therapeutics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Cephalgia Group. Dr. Dodick has stock in Healint. Dr. Dodick has stock in Theranica. Dr. Dodick has stock in Aural Analytics . Dr. Dodick has stock in Epien. Dr. Dodick has stock in Matterhorn. Dr. Dodick has stock in Ontologics. Dr. Dodick has stock in Precon Health. Dr. Dodick has stock in King Devick Technologies. Dr. Dodick has stock in Nocira. Dr. Dodick has stock in Exsano. Dr. Dodick has stock in Palion. Dr. Dodick has stock in AYYA Biosciences. Dr. Dodick has stock in Perfood. Dr. Dodick has stock in Cephalgia Group. Dr. Dodick has stock in Atria Health. Dr. Dodick has stock in Man and Science. Dr. Dodick has stock in Eigenlyfe. An immediate family member of Dr. Dodick has stock in ScotiaLyfe. Dr. Dodick has stock in Axon Therapeutics. The institution of Dr. Dodick has received research support from Department of Defense. The institution of Dr. Dodick has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Dodick has received research support from Henry Jackson Foundation. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has a non-compensated relationship as a Chair with American Brain Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Committee member/Course Director with American Academy of Neurology that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair/Immediate Past Chair with American Migraine Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair Global Patient Advocacy Coalition with International Headache Society that is relevant to AAN interests or activities.
Stephen D. Silberstein, MD, FAAN Dr. Silberstein has received publishing royalties from a publication relating to health care.
David J. Capobianco, MD, FAAN No disclosure on file
Peter Goadsby, MD, PhD, FRS Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CoolTech LLC. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health LLC. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kallyope. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seaport Therapeutics. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dr Reddy's. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orion Pharma. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society. The institution of Dr. Goadsby has received research support from NIHR. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has a non-compensated relationship as a Trustee with Migraine Trust that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Trustee with Organisation for Understanding Cluster Headache (UK) that is relevant to AAN interests or activities.
Kenneth C. Gorson, MD Dr. Gorson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Gorson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Gorson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. Dr. Gorson has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer.
Magdy H. Selim, MD, PhD Dr. Selim has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. The institution of Dr. Selim has received research support from NIH/NINDS. Dr. Selim has received publishing royalties from a publication relating to health care.
Ryan J. Uitti, MD, FAAN Dr. Uitti has nothing to disclose.
Harold P. Adams, Jr., MD, FAAN The institution of Dr. Adams has received research support from NINDS.
Stephan A. Mayer, MD Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Phagenesis. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ISchemaView. Dr. Mayer has stock in Neuroptics. Dr. Mayer has received publishing royalties from a publication relating to health care.
Allen J. Aksamit, Jr., MD, FAAN Dr. Aksamit has nothing to disclose.
Bart Demaerschalk, MD, MSc, FRCPC, FAAN Dr. Demaerschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Demaerschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Demaerschalk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Neurologist . The institution of Dr. Demaerschalk has received research support from NICHD.
Andres M. Lozano, MD Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Insightec. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Functional Neuromodulation.
Eelco F. Wijdicks, MD, FAAN Dr. Wijdicks has received publishing royalties from a publication relating to health care.
Amer Alshekhlee, MD No disclosure on file
Hamza I. Maqsood, MD Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Shashidhar Kori, MD Dr. Kori has received personal compensation for serving as an employee of Novilla Pharma. Dr. Kori has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Satsuma Pharma. Dr. Kori has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Tonix Pharma. Dr. Kori has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Exalys Pharma. Dr. Kori has received personal compensation in the range of $0-$499 for serving as a Consultant for NewBio Pharma. Dr. Kori has received personal compensation in the range of $0-$499 for serving as a Consultant for Afsci Pharma. Dr. Kori has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Trigemina Inc. Dr. Kori has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Novilla Pharma. Dr. Kori has received stock or an ownership interest from Novilla Pharma. Dr. Kori has received stock or an ownership interest from NewBio Pharma. Dr. Kori has received stock or an ownership interest from Tonix Pharma. Dr. Kori has received intellectual property interests from a discovery or technology relating to health care. Dr. Kori has received intellectual property interests from a discovery or technology relating to health care. Dr. Kori has received personal compensation in the range of $0-$499 for serving as a Reviewer of grant applications with Department of Defense.
Mark J. Alberts, MD, FAAN No disclosure on file
Michel T. Torbey, MD, MPH, FAAN Dr. Torbey has nothing to disclose.
Lawrence C. Newman, MD, FAAN Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan . Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Newman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Newman has received publishing royalties from a publication relating to health care.
Randolph S. Marshall, MD, FAAN The institution of Dr. Marshall has received research support from NIH. Dr. Marshall has received publishing royalties from a publication relating to health care.
Sheena K. Aurora, MD Dr. Aurora has received personal compensation for serving as an employee of Alzheimer's Association.
Denise H. Rhoney, PhD No disclosure on file
Todd D. Rozen, MD, FAAN No disclosure on file
Nabih Ramadan, MD, FAAN Dr. Ramadan has nothing to disclose.
Norman Latov, MD, PhD Dr. Latov has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Polyneuron. Dr. Latov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Therapath LLC. Dr. Latov has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Mcaloon & Freeman, PC. Dr. Latov has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Conway Homer PC. Dr. Latov has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sylvia Chin-Kaplan, LLC. The institution of Dr. Latov has received research support from Takeda. Dr. Latov has received publishing royalties from a publication relating to health care.
Amit Bar-Or, MD, FRCPC Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for cabaletta. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech.
Richard B. Lipton, MD, FAAN Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Micheline B. McCarthy, MD, PhD, FAAN No disclosure on file
Emmanuelle Waubant, MD, PhD, FAAN The institution of Dr. Waubant has received research support from NIH. The institution of Dr. Waubant has received research support from NMSS. The institution of Dr. Waubant has received research support from PCORI. The institution of Dr. Waubant has received research support from Race to Erase MS. The institution of Dr. Waubant has received research support from Roche. The institution of Dr. Waubant has received research support from Department of Defense. Dr. Waubant has received publishing royalties from a publication relating to health care.
Andrew S. Feigin, MD Dr. Feigin has received personal compensation for serving as an employee of Rho, Inc.. Dr. Feigin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kenai. Dr. Feigin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ADCS/ATRI. Dr. Feigin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. Dr. Feigin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Feigin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Feigin has received research support from Huntngton Study Group. The institution of Dr. Feigin has received research support from Prilenia.
E. W. Massey, MD, FAAN No disclosure on file
Silva Markovic-Plese, MD, FAAN Dr. Markovic-Plese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Markovic-Plese has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Eric J. Pappert, MD No disclosure on file
Jack P. Antel, MD, FAAN Dr. Antel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi, roche, biogen, wave,nervgen. The institution of Dr. Antel has received research support from Novartis canada bristol myers squib. Dr. Antel has a non-compensated relationship as a past president with ACTRIMS that is relevant to AAN interests or activities.
Edward M. Manno, MD, FAAN No disclosure on file
David Eidelberg, MD, FAAN Dr. Eidelberg has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for MeiraGTx. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TreeFrog Therapeutics. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Blue Rock Therapeutics, Inc.. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SANA Biotechnology, Inc. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bio Vie, Inc.. Dr. Eidelberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for KenaiTx, Inc.. Dr. Eidelberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspen Neuroscience. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Oxford University Press. The institution of Dr. Eidelberg has received research support from The Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Eidelberg has received research support from Lupus Research Alliance. The institution of Dr. Eidelberg has received research support from National Institutes of Health. The institution of Dr. Eidelberg has received research support from Blue Rock Therapeutics. The institution of Dr. Eidelberg has received research support from National Institute of Neurological Disorders and Stroke. The institution of Dr. Eidelberg has received research support from The Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Eidelberg has received research support from National Institute of Allergy and Infectious Diseases. The institution of Dr. Eidelberg has received research support from Aspen Neurosciences, Inc. . The institution of Dr. Eidelberg has received research support from NIH. Dr. Eidelberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Eidelberg has received intellectual property interests from a discovery or technology relating to health care.
Richard A. Bernstein, MD No disclosure on file
Anthony J. Furlan, MD, FAAN No disclosure on file
Robert D. Brown, Jr., MD, MPH, FAAN Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Craig H Neilsen Foundation. The institution of Dr. Brown has received research support from National Institutes of Health/NINDS. Dr. Brown has received publishing royalties from a publication relating to health care.
Christine Klein, MD Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Centogene and Retromer Therapeutics. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Mov Disord, Ann Neurol, Science Adv. The institution of Dr. Klein has received research support from Centogene. Dr. Klein has received publishing royalties from a publication relating to health care.
Eduardo A. De Sousa, MD, FAAN No disclosure on file
Derk Krieger, MD No disclosure on file
Allan Purdy, MD Dr. Purdy has nothing to disclose.
Qaisar A. Shah, MD No disclosure on file
Lan Zhou, MD, PhD The institution of Dr. Zhou has received research support from NIH.
Howard L. Weiner, MD Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana Life Sciences. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for vTv Therapeutics. Dr. Weiner has stock in vTv Therapeutics. The institution of Dr. Weiner has received research support from National Institute of Health. The institution of Dr. Weiner has received research support from National MS Society. The institution of Dr. Weiner has received research support from Genzyme Corp. The institution of Dr. Weiner has received research support from Genentech, Inc. . The institution of Dr. Weiner has received research support from Verily Life Sciences LLC. The institution of Dr. Weiner has received research support from EMD Serono, Inc..
No disclosure on file
David Z. Wang, DO, FAHA, FAAN Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Mediwelcome.
Ettore Beghi, MD, FAAN No disclosure on file
Max J. Hilz, MD, PhD, FAAN Dr. Hilz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SANOFI. Dr. Hilz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Hilz has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Neeraj Badjatia, MD The institution of Dr. Badjatia has received research support from NIH/DOD.
Robert Cowan, MD, FAAN Dr. Cowan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Cowan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Cowan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for lundbeck. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biohavenn. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbviie. Dr. Cowan has stock in Percept. Dr. Cowan has received intellectual property interests from a discovery or technology relating to health care. Dr. Cowan has received intellectual property interests from a discovery or technology relating to health care. Dr. Cowan has received publishing royalties from a publication relating to health care.
Dennis W. Dickson, MD Dr. Dickson has nothing to disclose.
Thomas C. Chelimsky, MD Dr. Chelimsky has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Proctor & Gamble. Dr. Chelimsky has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Various Legal Firms. Dr. Chelimsky has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various Legal Firms. Dr. Chelimsky has received stock or an ownership interest from PainSTakers, LLC. The institution of Dr. Chelimsky has received research support from NIDDK. The institution of Dr. Chelimsky has received research support from Advancing a Healthier Wisconsin.
William Ondo, MD Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TEVA. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ACADIA. Dr. Ondo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ACADIA. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Ondo has received research support from Fascicle. The institution of Dr. Ondo has received research support from Cerevance. The institution of Dr. Ondo has received research support from AskBio. Dr. Ondo has received publishing royalties from a publication relating to health care.
Robert L. Rodnitzky, MD, FAAN No disclosure on file
Joel Gutierrez, MD Dr. Gutierrez has nothing to disclose.
Graham Glass, MD No disclosure on file
Shyam Prabhakaran, MD Dr. Prabhakaran has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Cincinnati. Dr. Prabhakaran has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Cincinnati. The institution of Dr. Prabhakaran has received research support from NIH . The institution of Dr. Prabhakaran has received research support from AHRQ. Dr. Prabhakaran has received publishing royalties from a publication relating to health care.
Osman Kozak, MD No disclosure on file
Axel Rosengart, MD, PhD, FAAN No disclosure on file
Scott Vota, DO, FAAN No disclosure on file
Mark F. Lew, MD, FAAN Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for kyowa. Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for neurocrine. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acorda. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RegenXBio. Dr. Lew has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Kyowa. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for acorda. The institution of Dr. Lew has received research support from MJFF. Dr. Lew has received research support from NIH.
Marinos C. Dalakas, MD, FAAN Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols, . Dr. Dalakas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dysimmune Diseases Foundation. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurology (TAND). Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink.
Anne S. Lindblad, PhD No disclosure on file
Emmanuel Carrera No disclosure on file
Keith A. Josephs, Jr., MD, FAAN Dr. Josephs has nothing to disclose.
Michael J. Schneck, MD, FAAN An immediate family member of Dr. Schneck has received personal compensation for serving as an employee of Cellcarta. Dr. Schneck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for HLT Medical. Dr. Schneck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Miscellaneous legal firms. Dr. Schneck has stock in Baxter Labs. The institution of Dr. Schneck has received research support from NIH.
Saud Sadiq, BS, FAAN Ms. Brewi has nothing to disclose.
Christopher Bever, Jr., MD, MBA, FAAN No disclosure on file
J. Americo M. Fernandes, Jr., MD, FAAN Dr. Fernandes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Columbia University. The institution of Dr. Fernandes has received research support from MGH philanthropy (Clene, Seelos, UCB, Biohaven, Prilenia, Denali Therapeutics, Calico Life Sciences. The institution of Dr. Fernandes has received research support from Columbia University. The institution of Dr. Fernandes has received research support from PTC Therapeutics. The institution of Dr. Fernandes has received research support from Clene.
Muhammad Nashatizadeh, MD No disclosure on file
Christine Lebrun Frenay, MD, FAAN Dr. Lebrun Frenay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique. The institution of Dr. Lebrun Frenay has received research support from FRANCE SEP.
Gregory Christoforidis No disclosure on file
Fernando Cendes, MD, PhD, FAAN Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for United Medical – Brazil. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zodiac Pharma . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eurofarma – Brazil . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology - Epilepsy. The institution of Dr. Cendes has received research support from São Paulo Research Foundation - FAPESP. The institution of Dr. Cendes has received research support from Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil . The institution of Dr. Cendes has received research support from NIH.
Andrew McKeon, MD The institution of Dr. McKeon has received research support from National Institutes of Health. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received publishing royalties from a publication relating to health care.
Jean-Philippe Brandel No disclosure on file
Jean-Jacques Hauw No disclosure on file
Daniel F. Hanley, MD, FAAN Dr. Hanley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurotrope. Dr. Hanley has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various law firms. The institution of Dr. Hanley has received research support from NIH/NCATS. The institution of Dr. Hanley has received research support from NIH/NINDS.
Timothy L. Vollmer, MD, FAAN The institution of Dr. Vollmer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen IDEC. The institution of Dr. Vollmer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siranax. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers Squib. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bios. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Vollmer has received research support from Rocky Mountain MS Center. The institution of Dr. Vollmer has received research support from Biogen. The institution of Dr. Vollmer has received research support from Actelion. The institution of Dr. Vollmer has received research support from Genentech/Roche. The institution of Dr. Vollmer has received research support from Anokion. The institution of Dr. Vollmer has received research support from TG Therapeutics.
Denise I. Campagnolo, MD, MS Dr. Campagnolo has received personal compensation for serving as an employee of Biogen. Dr. Campagnolo has received stock or an ownership interest from Biogen.
Shin J. Oh, MD, FAAN No disclosure on file
Anat Achiron, MD, PhD, FAAN Dr. Achiron has nothing to disclose.
Ergun Y. Uc, MD An immediate family member of Dr. Uc has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for American Board of Pediatrics. The institution of Dr. Uc has received research support from Department of Veterans Affairs. The institution of Dr. Uc has received research support from Department of Defense. The institution of an immediate family member of Dr. Uc has received research support from NIH. The institution of Dr. Uc has received research support from NIH. The institution of Dr. Uc has received research support from NIH. The institution of Dr. Uc has received research support from Parkinson's Foundation. The institution of Dr. Uc has received research support from NIH.
Myoung C. Lee, MD, FAAN No disclosure on file
Sun Ju Chung, MD, PhD, FAAN Dr. Chung has nothing to disclose.
Brigitte Stemper, MD No disclosure on file
Timothy Lynch, MD Dr. Lynch has nothing to disclose.
Pasquale Ferrante, MD No disclosure on file
Peter P. Pramstaller, MD No disclosure on file
Norman Putzki, MD No disclosure on file
Manoj Kumar No disclosure on file
Helene Zephir Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for BIogen Idec. Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for novartis. Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for BMS. Helene Zephir has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion.
Patrick Vermersch Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS-Celgene. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ad Scientiam. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for La revue des microbiotes. The institution of Patrick Vermersch has received research support from Roche. The institution of Patrick Vermersch has received research support from Sanofi.
Matthew Lee, MD No disclosure on file
Takayoshi Shimohata, MD, FAAN Dr. Shimohata has nothing to disclose.
Jikke-Mien Niermeijer, MD No disclosure on file
Nicolette C. Notermans, MD, PhD No disclosure on file
John H. Wokke, MD, PhD No disclosure on file
Takahiro Iizuka, MD The institution of Dr. Iizuka has received research support from EUROIMMUN Japan Co., Ltd.
Saori Miyakawa No disclosure on file
Junichi Hamada, MD, PhD No disclosure on file
James H. Bower, MD, MSc, FAAN The institution of Dr. Bower has received research support from Abbvie.
Manikum Moodley, MD, FAAN Dr. Moodley has nothing to disclose.
Alejandro A. Rabinstein, MD, FAAN Dr. Rabinstein has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shionogi . Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceribell. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical care/NCS-Springer. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters/UptoDate. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO/DynaMed. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care.
Ruggero Capra, MD Dr. Capra has nothing to disclose.
Cinzia Cordioli, MD Dr. Cordioli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Dr. Cordioli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Cordioli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Roberto Bergamaschi Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Luisa Imberti No disclosure on file
Claudio Mariani, MD No disclosure on file
Pierluigi Bertora No disclosure on file
Seong B. Koh, MD No disclosure on file
Anne Donnet, MD No disclosure on file
Gal Ifergane, MD Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medison pharma. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceretrieve. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medison pharma. Dr. Ifergane has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Ifergane has received research support from Teva.
Todd J. Schwedt, MD, FAAN Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. The institution of Dr. Schwedt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Salvia. Dr. Schwedt has or had stock in Nocira.Dr. Schwedt has or had stock in Allevalux. The institution of Dr. Schwedt has received research support from National Institutes of Health. The institution of Dr. Schwedt has received research support from United States Department of Defense. The institution of Dr. Schwedt has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Schwedt has received research support from Henry Jackson Foundation. The institution of Dr. Schwedt has received research support from Pfizer. The institution of Dr. Schwedt has received research support from National Headache Foundation. The institution of Dr. Schwedt has received research support from American Heart Association. The institution of Dr. Schwedt has received research support from AbbVie. The institution of Dr. Schwedt has received research support from Flinn Foundation. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received publishing royalties from a publication relating to health care.
Masaaki Niino, MD No disclosure on file
Nicolas Dupre, MD, FAAN Dr. Dupre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea Therapeutics Canada. The institution of Dr. Dupre has received research support from ARSACS Foundation. The institution of Dr. Dupre has received research support from CHUdeQuebec Foundation.
Steve Verreault, MD The institution of Dr. Verreault has received research support from BMS. The institution of Dr. Verreault has received research support from Portola. The institution of Dr. Verreault has received research support from Daichii Sankyo.
Arun V. Talkad, MD, BA Dr. Talkad has nothing to disclose.
Itzik Wirguin, MD No disclosure on file
Hideto Nakajima, MD No disclosure on file
Pierangelo Barbero, MD No disclosure on file
Bruno Ferrero No disclosure on file
Luca Durelli, MD No disclosure on file
Marinella Clerico, MD Dr. Clerico has nothing to disclose.
Albert C. Ludolph, MD Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Ludolph has received personal compensation in the range of $0-$499 for serving as a Consultant for FundaMental Pharma . Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon . Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharma. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biologix FZCo.. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zambon.
Angelo Ghezzi, MD No disclosure on file
Anna Feldman No disclosure on file
Michael Gurevich No disclosure on file
Robert Zivadinov, MD, PhD, FAAN The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Niranjan N. Singh, MD, FAAN Dr. Singh has nothing to disclose.
Jennifer A. Frontera, MD Dr. Frontera has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FirstKindMedical. Dr. Frontera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Physician Education Resource. The institution of Dr. Frontera has received research support from NIH. The institution of Dr. Frontera has received research support from Alexion. Dr. Frontera has received publishing royalties from a publication relating to health care.
Jan Claassen, MD, PhD Dr. Claassen has stock in iCE Neurosystems. The institution of Dr. Claassen has received research support from NINDS. The institution of Dr. Claassen has received research support from McDonnel Foundation. Dr. Claassen has received publishing royalties from a publication relating to health care. Dr. Claassen has received publishing royalties from a publication relating to health care.
Fred Rincon, MD Dr. Rincon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NeuroCrit, LLC. Dr. Rincon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for NeuroCrit LLC.
Susann Junghanns, MD No disclosure on file
Heinz Reichmann, MD, FAAN Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyowa. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zambon. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wissenschaftsverlag.
Petr Kanovsky, PhD Dr. Kanovsky has nothing to disclose.
Judith Aharon-Peretz, MD Dr. Aharon-Peretz has nothing to disclose.
Alain Autret, MD, PhD No disclosure on file
Bruce I. Ovbiagele, MD, MSc, FAAN Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to AAN interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to AAN interests or activities.
Enrico Ferrante No disclosure on file
Mitch T. Wallin, MD, MPH, FAAN The institution of Dr. Wallin has received research support from NMSS.
Robert Kane, PhD, ABPP-CN No disclosure on file
Brian Silver, MD, FAAN Dr. Silver has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various legal firms. Dr. Silver has received intellectual property interests from a discovery or technology relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Women's Health Initiative. Dr. Silver has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Best Doctors, Inc./Teladoc, Inc.. Dr. Silver has a non-compensated relationship as a Consultant with ABPN that is relevant to AAN interests or activities. Dr. Silver has a non-compensated relationship as a Member, Regional Board of Directors with American Heart Association that is relevant to AAN interests or activities.
Sophie Rimbaux No disclosure on file
Marc G. Verny, MD, PhD No disclosure on file
Hans-Peter Hartung, MD, FAAN Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Masatoyo Nishizawa, MD No disclosure on file
Hitoshi Takahashi No disclosure on file
Christian Wider, MD No disclosure on file
Ja-Seong Koo, MD No disclosure on file
Jong-Moo Park, MD No disclosure on file
Ohyun Kwon No disclosure on file
Byung-kun Kim, MD Dr. Kim has nothing to disclose.
Mustapha A. Ezzeddine, MD, FAAN The institution of Dr. Ezzeddine has received research support from NIH.
Jill L. Ostrem, MD, FAAN Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz . Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Superness. Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AcureX. Dr. Ostrem has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspen. Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders. The institution of Dr. Ostrem has received research support from Neuroderm. The institution of Dr. Ostrem has received research support from Boston Scientific. The institution of Dr. Ostrem has received research support from Medtronic. The institution of Dr. Ostrem has received research support from Rune.
Stephen B. Shrewsbury, MD Dr. Shrewsbury has received personal compensation for serving as an employee of Impel NeuroPharma. Dr. Shrewsbury has received stock or an ownership interest from Impel NeuroPharma.
Benjamin M. Greenberg, MD, FAAN Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Clene. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Greenberg has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Siegel Rare Neuroimmune Association. Dr. Greenberg has or had stock in GenrAb.Dr. Greenberg has or had stock in Clene.Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Greenberg has received publishing royalties from a publication relating to health care.
Gary R. Cutter, PhD Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for onsulting or Advisory Boards: Alexion, Antisense Therapeutics/Percheron, Avotres, Biogen, Clene Nanomedicine, Clinical Trial Solutions LLC, Endra Life Sciences, Cognito Therapeutics, Genzyme, Genentech, Immunic, Klein-Buendel Incorporated, Kyverna Therapeutics, Inc. , Linical, Merck/Serono, Noema, Neurogenesis, Perception Neurosciences, Protalix Biotherapeutics, Regeneron, Revelstone Consulting, Roche, SAB Biotherapeutics, Sapience Therapeutics, Scott&Scott LLP, Tenmile.. Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Data and Safety Monitoring Boards: Applied Therapeutics, AI therapeutics, AMO Pharma, Argenx, Astra-Zeneca, Avexis Pharmaceuticals, Bristol Meyers Squibb, CSL Behring, Cynata Therapeutics, DiamedicaTherapeutics, Horizon Pharmaceuticals, Immunic, Inhibrix, Karuna Therapeutics, Kezar Life Sciences, Medtronic, Merck, Meiji Seika Pharma, Mitsubishi Tanabe Pharma Holdings, Prothena Biosciences, Novartis, Pipeline Therapeutics (Contineum), Regeneron, Sanofi-Aventis, Teva Pharmaceuticals, United BioSource LLC, University of Texas Southwestern.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Ruth-Ann Marrie, MD, PhD The institution of Dr. Marrie has received research support from CIHR. The institution of Dr. Marrie has received research support from MS Canada. The institution of Dr. Marrie has received research support from National MS Society. The institution of Dr. Marrie has received research support from Crohn's and Colitis Canada. The institution of Dr. Marrie has received research support from US Department of Defense. The institution of Dr. Marrie has received research support from The Arthritis Society. The institution of Dr. Marrie has received research support from CMSC.
Ramesh Khurana, MD, FAAN No disclosure on file
Francisco De Assis Gondim, MD, PhD, MSc, FAAN No disclosure on file
Iscia Lopes-Cendes, MD, PhD No disclosure on file
Marcondes C. Franca, Jr., MD Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Franca has received research support from FARA.
Ashish Nanda, MD No disclosure on file
Carol Moore No disclosure on file
Ramon R. Diaz-Arrastia, MD, PhD, FAAN Dr. Diaz-Arrastia has stock in BrainBox, LLC. Dr. Diaz-Arrastia has stock in Nia Therpeutics. The institution of Dr. Diaz-Arrastia has received research support from National Institutes of Health. The institution of Dr. Diaz-Arrastia has received research support from Department of Defense.
Caryn Harper No disclosure on file
Paul Larson No disclosure on file
Zbigniew K. Wszolek, MD, FAAN Dr. Wszolek has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Polish Neurological Society/Via Medica. Dr. Wszolek has received intellectual property interests from a discovery or technology relating to health care.
Michael L. Reed, PhD The institution of Dr. Reed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Reed has received research support from Allergan. The institution of Dr. Reed has received research support from Dr Reddy's Labs/Promius. The institution of Dr. Reed has received research support from Allay Lamp. Dr. Reed has a non-compensated relationship as a Research Analyst with National Headache Foundation that is relevant to AAN interests or activities.
Stefan Schwarz, MD No disclosure on file
William B. Young, MD, FAAN Dr. Young has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Pharmaceuticals. Dr. Young has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly and Company. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven Pharmaceuticals Inc. Dr. Young has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly and Company. Dr. Young has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Young has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Coalition for Headache and Migraine Patients. Dr. Young has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Miles for Migraine. The institution of Dr. Young has received research support from Amgen. The institution of Dr. Young has received research support from Cumberland. The institution of Dr. Young has received research support from Eli Lilly. The institution of Dr. Young has received research support from Novartis. The institution of Dr. Young has received research support from PCORI. The institution of Dr. Young has received research support from Satsuma. The institution of Dr. Young has received research support from Scion. The institution of Dr. Young has received research support from Teva. The institution of Dr. Young has received research support from Zosano.
Ichiro Nakashima, MD, PhD Dr. Nakashima has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Nakashima has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Nakashima has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Nakashima has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai. Dr. Nakashima has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Nakashima has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Nakashima has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Nakashima has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Chugai. The institution of Dr. Nakashima has received research support from LSI Medience. The institution of Dr. Nakashima has received research support from BML.
Andrew Nelsen, PharmD No disclosure on file
P. James B. Dyck, MD, FAAN Dr. Dyck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea/Ionis.
Nizar Souayah, MD, FAAN Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Ralf Gold, MD Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
Joseph Hentz No disclosure on file
Michelle Lener, PharmD No disclosure on file
Susan A. McDonald, MA No disclosure on file
Andrew M. Naidech, MD, FAAN Dr. Naidech has received publishing royalties from a publication relating to health care.
Hanna-Maija Kuusisto, MD No disclosure on file
Christopher H. Gibbons, MD, FAAN Dr. Gibbons has received personal compensation for serving as an employee of CND Life Sciences. Dr. Gibbons has or had stock in CND Life Sciences.Dr. Gibbons has received publishing royalties from a publication relating to health care.
James U. Adelman, MD No disclosure on file
Irina Elovaara, MD, PhD No disclosure on file
Yilong Ma, PhD The institution of Dr. Ma has received research support from AskBio. The institution of Dr. Ma has received research support from Aspen Neuroscience . The institution of Dr. Ma has received research support from Blue Rock . The institution of Dr. Ma has received research support from Bayer.
John W. Lindsey, MD Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Banner Life Sciences. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mapi. Dr. Lindsey has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Teva. The institution of Dr. Lindsey has received research support from Genentech.
Frederick E. Munschauer III, MD, FAAN Dr. Munschauer has received personal compensation for serving as an employee of Emalex Biosciences. Dr. Munschauer has stock in Emalex Biosciences.
Bianca Weinstock-Guttman, MD Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Alfred W. Sandrock, MD, PhD No disclosure on file
Gavin Giovannoni, MD Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck KGaA. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche-Genentech. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astoria Biologica. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape.
Lisa Elizabeth M. Costelloe, MD The institution of Dr. Costelloe has received research support from Enterprise Ireland.
Niall Tubridy, MD Dr. Tubridy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis .
Karine Viala No disclosure on file
Thierry Maisonobe No disclosure on file
Pierre Bouche, MD No disclosure on file
Diego Franciotta, MD Dr. Franciotta has nothing to disclose.
John Campbell No disclosure on file
Murali Ramanathan, PhD The institution of Dr. Ramanathan has received research support from DoD. Dr. Ramanathan has received publishing royalties from a publication relating to health care.
Bernhard Hemmer, MD No disclosure on file
Jayawant N. Mandrekar, PhD Dr. Mandrekar has nothing to disclose.
Igor Nestrasil No disclosure on file
Sabine Cepok No disclosure on file
Gloria Von Geldern, MD, FAAN The institution of Dr. Von Geldern has received research support from Novartis. The institution of Dr. Von Geldern has received research support from Contineum Therapeutics. Dr. Von Geldern has received personal compensation in the range of $0-$499 for serving as a DSMB member with NIH, NINDS. Dr. Von Geldern has a non-compensated relationship as a editorial board member with MS and Related Disorders Journal that is relevant to AAN interests or activities.
Jun Lee, MD No disclosure on file
Kyung Mi Oh, MD No disclosure on file
Byung-Jo Kim No disclosure on file
Kun W. Park, MD, PhD No disclosure on file
Andre Ferreira No disclosure on file
Elena Moro, MD, FAAN Dr. Moro has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Moro has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Moro has received research support from Abbott. The institution of Dr. Moro has received research support from Medtronic.
Francis E. Bolgert, MD No disclosure on file
Guillermo Videla, MD No disclosure on file
Stephen H. Landy, MD, FAAN Dr. Landy has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Allergan/Abbvie, Amgen, Biohaven, Lilly, Lundbeck, Teva.
Per Solberg Sorensen, MD, PhD, FAAN Dr. Sorensen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA.
Finn Sellebjerg, MD Dr. Sellebjerg has received personal compensation for serving as an employee of Danish Multiple Sclerosis Society. Dr. Sellebjerg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Gangsted Foundation. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Warwara Larsen Foundation. The institution of Dr. Sellebjerg has received research support from Biogen. The institution of Dr. Sellebjerg has received research support from Merck. The institution of Dr. Sellebjerg has received research support from Novartis. The institution of Dr. Sellebjerg has received research support from Sanofi Genzyme. Dr. Sellebjerg has received publishing royalties from a publication relating to health care.
Sara L. Schrader, MD No disclosure on file
Marcia F. Rupnow, PhD No disclosure on file
Osvaldo J. Nascimento, MD, PhD, FAAN Dr. Nascimento has nothing to disclose.
Marcos R. De Freitas, MD, PhD No disclosure on file
Elizabeth Loder, MD, MPH Dr. Loder has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of New England. The institution of Dr. Loder has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The BMJ.
Andrei Voustianiouk No disclosure on file
Robert H. Goertsches, PhD No disclosure on file
Russell L. Chin, MD No disclosure on file
Thomas Brannagan III, MD, FAAN Dr. Brannagan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brannagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia. Dr. Brannagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zenica. Dr. Brannagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. The institution of Dr. Brannagan has received research support from Alnylam. The institution of Dr. Brannagan has received research support from Abcuro. The institution of Dr. Brannagan has received research support from Ionis. The institution of Dr. Brannagan has received research support from Vertex. The institution of Dr. Brannagan has received research support from NMD Pharma.
Howard W. Sander, MD, FAAN Dr. Sander has received personal compensation for serving as an employee of Grifols. Dr. Sander has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Law firm.
Mohammed Rehman, DO Dr. Rehman has nothing to disclose.
Ilan Ziv, MD No disclosure on file
Ayelet Reshef No disclosure on file
Kamal R. Chemali, MD Dr. Chemali has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Chemali has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. The institution of Dr. Chemali has received research support from Sjögren's Foundation. The institution of Dr. Chemali has received research support from NIH.
Mustafa Ertas No disclosure on file
Akiko Imamura, MD, PhD No disclosure on file
M Lanteri-Minet No disclosure on file
Robert E. Chen, MD, MBBChir Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Chen has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Federation of Clinical Neurophysiology. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders. The institution of Dr. Chen has received research support from Canadian Institutes of Health Research. The institution of Dr. Chen has received research support from Natural Science and Engineering Research Council of Canada. Dr. Chen has received research support from Parkinson Foundation. The institution of Dr. Chen has received research support from National Organization for Rare Disease. The institution of Dr. Chen has received research support from Abbvie.
Yousef Mohammad, MD No disclosure on file
Irene Pichler No disclosure on file
Jerzy Slowinski No disclosure on file
Tamer Abdelhak, MD Dr. Abdelhak has nothing to disclose.
A. D. Rothner, MD No disclosure on file
Abraham N. Lieberman, MD, FAAN No disclosure on file
Pierre Labauge, MD Dr. Labauge has nothing to disclose.
Chris Tang, MD No disclosure on file
Svetlana Lenina No disclosure on file
Thomas J. Wolfe, MD No disclosure on file
Kara Patrick No disclosure on file
Linga V. Reddy, MD No disclosure on file
Didier P. Cros, MD No disclosure on file
Peter Siao Tick Chong, MD No disclosure on file
Til Menge, MD, FAAN No disclosure on file
Leonard van den Berg, MD The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ferrrer. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Projenx. Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept. The institution of Dr. Van den Berg has received research support from Netherlands ALS Foundation.
Hessel Franssen No disclosure on file
Mark Agius, MD No disclosure on file
Edwin H. Kolodny, MD, FAAN No disclosure on file
Tjalf Ziemssen, MD, FAAN Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS . Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Dresden Internation University. The institution of Dr. Ziemssen has received research support from Novartis. The institution of Dr. Ziemssen has received research support from Merck. The institution of Dr. Ziemssen has received research support from Sanofi. The institution of Dr. Ziemssen has received research support from BMS. The institution of Dr. Ziemssen has received research support from Roche.
Hauke Schneider, MD The institution of Dr. Schneider has received research support from Medical Faculty, University of Augsburg, Germany.
Michael J. Kaminski, MD, FAAN No disclosure on file
Gustavo J. Rodriguez, MD Dr. Rodriguez has nothing to disclose.
Viktor Szeder, MD, PhD Dr. Szeder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Szeder has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Carroll, Kelly, Trotter, Franzen, McBride & Peabody LLP. Dr. Szeder has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Peabody and Buccini LLP.
Jose L. Ruiz-Sandoval, MD Dr. Ruiz-Sandoval has nothing to disclose.
Richard A. Hughes, MD Dr. Hughes has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi.
Susan E. Goelz, PhD No disclosure on file
Rocio S. Lopez-Diego, MD, PhD No disclosure on file
Michel Panisset, MD No disclosure on file
Vera Bril, MD Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Powell Mansfield. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta (now J&J). Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Bril has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Bril has received research support from UCB. The institution of Dr. Bril has received research support from Argenx. The institution of Dr. Bril has received research support from Momenta (now J&J). The institution of Dr. Bril has received research support from Immunovant. The institution of Dr. Bril has received research support from Alexion. The institution of Dr. Bril has received research support from Takeda. The institution of Dr. Bril has received research support from Grifols. The institution of Dr. Bril has received research support from CSL. The institution of Dr. Bril has received research support from Octapharma. The institution of Dr. Bril has received research support from Akcea. The institution of Dr. Bril has received research support from Ionis. The institution of Dr. Bril has received research support from Viela Bio (now Horizon). Dr. Bril has received intellectual property interests from a discovery or technology relating to health care.
Pieter Van Doorn, MD The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hansa. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octapharma. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Grifols. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octapharma. The institution of Dr. Van Doorn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Van Doorn has received publishing royalties from a publication relating to health care.
Ingemar S. Merkies, MD No disclosure on file
Joseph Y. Matsumoto, MD Dr. Matsumoto has nothing to disclose.
Lisa Bance No disclosure on file
Jonathan P. Gladstone, MD Dr. Gladstone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lily. Dr. Gladstone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Gladstone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Gladstone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lily. Dr. Gladstone has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Gladstone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Gladstone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Gladstone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aralez. Dr. Gladstone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Gladstone has received publishing royalties from a publication relating to health care.
Min-Suk Yoon, MD No disclosure on file
Nir Giladi, MD, FAAN Dr. Giladi has received personal compensation in the range of $0-$499 for serving as a Consultant for Sionara. Dr. Giladi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDerm. Dr. Giladi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pharma2B. Dr. Giladi has stock in Vibrant. Dr. Giladi has stock in Lysosomal Therapeutics . The institution of Dr. Giladi has received research support from The Michael J Fox Foundation. The institution of Dr. Giladi has received research support from The National Parkinson Foundation. The institution of Dr. Giladi has received research support from The European Union . The institution of Dr. Giladi has received research support from The Israel Science Foundation. The institution of Dr. Giladi has received research support from Biogen . The institution of Dr. Giladi has received research support from Ionis. The institution of Dr. Giladi has received research support from Sieratzki Family Foundation . The institution of Dr. Giladi has received research support from The Aufzien Academic Center in Tel-Aviv University.
Lisa K. Mannix, MD No disclosure on file
Sa-Yoon Kang, MD No disclosure on file
Jean-Marc Leger, MD, FAAN No disclosure on file
Daniel Tranel, PhD No disclosure on file
Frederick J. Derosier, DO No disclosure on file
Yves Samson, MD No disclosure on file
P. D. Charles, MD, FAAN Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Iota. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceraxis. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aspen Neuroscience. Dr. Charles has stock in Arena Therapeutics. The institution of Dr. Charles has received research support from Pharma 2 B. The institution of Dr. Charles has received research support from Intec. The institution of Dr. Charles has received research support from Merz. The institution of Dr. Charles has received research support from Novartis. The institution of Dr. Charles has received research support from Aeon. The institution of Dr. Charles has received research support from Impax. The institution of Dr. Charles has received research support from AskBio. The institution of Dr. Charles has received research support from BlueRock. The institution of Dr. Charles has received research support from AbbVie. The institution of Dr. Charles has received research support from Ipsen.
Sylvia M. Lucas, MD, PhD No disclosure on file
Neil R. Friedman, MD, MBChB No disclosure on file
Holger Kaube, MD No disclosure on file
Latha Ganti, MD, MS, MBA, FACEP Dr. Ganti has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Ganti has received publishing royalties from a publication relating to health care.
Wyatt W. Decker No disclosure on file
Clarissa L. Yasuda, MD, PhD Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for LIBBS. Prof. Yasuda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBOTT. Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for LIBBS.
Susan M. Baser, MD No disclosure on file
Kwang W. Lee, MD No disclosure on file
Walter R. Royal III, MD No disclosure on file
Jean M. Vallat, MD No disclosure on file
Katherine T. Dawson, MD No disclosure on file
Maria R. Tola, MD No disclosure on file
Dimos Dimitrios D. Mitsikostas, MD, PhD The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Leli Lilly. The institution of Dr. Mitsikostas has received research support from Eli Lilly. Dr. Mitsikostas has a non-compensated relationship as a Co-Chair of Headache Panel with EAN that is relevant to AAN interests or activities. Dr. Mitsikostas has a non-compensated relationship as a President with Hellenic Headache Society that is relevant to AAN interests or activities. Dr. Mitsikostas has a non-compensated relationship as a Associate Editor with J Headache Pain that is relevant to AAN interests or activities. Dr. Mitsikostas has a non-compensated relationship as a Associate Editor with Frontier Neurology that is relevant to AAN interests or activities.
Valeria Tugnoli No disclosure on file
Andrew H. Chan, MD No disclosure on file
Seong H. Choi, MD, PhD No disclosure on file
Paolo Livrea No disclosure on file
Pariwat Thaisetthawatkul, MD, FAAN Dr. Thaisetthawatkul has nothing to disclose.
Heinz Wiendl, MD, FAAN Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for INmune Bio_Syneos Health. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Muna Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Myrobalan Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSL Group. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Red Nucleus. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Swiss Multiple Sclerosis Society. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teladoc Health. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Toleranzia . Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocryst. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biontech. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received research support from Alexion Syneos Health iVH UK Ltd.. The institution of Dr. Wiendl has received research support from Deutsche Myasthenie-Gesellschaft. The institution of Dr. Wiendl has received research support from Winicker Norimed GmbH. The institution of Dr. Wiendl has received research support from Novartis. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
Anelyssa Cysne Frota D' Abreu, MD, PhD, MPH, FAAN The institution of Dr. Cysne Frota D' Abreu has received research support from U.S. NIH Institute on Aging. The institution of Dr. Cysne Frota D' Abreu has received research support from Biogen. The institution of Dr. Cysne Frota D' Abreu has received research support from American College Of Radiology. The institution of Dr. Cysne Frota D' Abreu has received research support from COGNITION THERAPEUTICS, INC.. The institution of Dr. Cysne Frota D' Abreu has received research support from Eli Lilly. The institution of Dr. Cysne Frota D' Abreu has received research support from Jansen. Dr. Cysne Frota D' Abreu has received personal compensation in the range of $10,000-$49,999 for serving as a Lecturer with Pri_med.
Giovanni Antonini No disclosure on file
Pablo Bonardo, MD Dr. Bonardo has nothing to disclose.
Swati Sathe, MD Dr. Sathe has received personal compensation in the range of $0-$499 for serving as a Expert opinion with FirstThought.IO.
Masato Kanazawa, MD, FAAN Dr. Kanazawa has nothing to disclose.
Rocco Quatrale, MD No disclosure on file
Erica Grazioli, DO No disclosure on file
Scott McGinnis, MD Dr. McGinnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai.
Reza Behrouz, DO, PhD, FAAN No disclosure on file
Zohara Sternberg, PhD No disclosure on file
Boris Shihman, MD No disclosure on file
Luisa M. Villar Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol-Myers Squibb. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol-Myers Squibb. The institution of Luisa M. Villar has received research support from European Union. The institution of Luisa M. Villar has received research support from Instituto de Salud Carlos III (Spanish Goverment).
Serkan Ozakbas, MD Dr. Ozakbas has nothing to disclose.
M. Fernanda Bellolio, MD No disclosure on file
Bruno Coutinho, MD No disclosure on file
Catalina Cleves, MD Dr. Cleves has nothing to disclose.
Alasdair Coles, MD, PhD Dr. Coles has nothing to disclose.
Giulia Contessa No disclosure on file
Ana Djarmati, PhD No disclosure on file
Dilesh Doshi, PharmD Dr. Doshi has received personal compensation for serving as an employee of Acadia Pharmaceuticals.
Sailaja Enduri, MD No disclosure on file
Nuria Garcia-Barragan No disclosure on file
Maira Gironi No disclosure on file
Jaesung Kim, MD No disclosure on file
Clement Hamani No disclosure on file
Ann Hoff No disclosure on file
Ben M. Illigens, MD Dr. Illigens has received personal compensation for serving as an employee of Target Health. Dr. Illigens has received personal compensation for serving as an employee of BC Platforms. Dr. Illigens has received personal compensation for serving as an employee of NOVA Discovery. Dr. Illigens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RDP Pharma. Dr. Illigens has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Biomind Labs. Dr. Illigens has a non-compensated relationship as a Director with Partners for Patients that is relevant to AAN interests or activities.
Jung-Ju Lee, MD, PhD No disclosure on file
Rosa Rademakers, PhD Rosa Rademakers, PhD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mayo Clinic. Rosa Rademakers, PhD has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arkuda Therapeutics. Rosa Rademakers, PhD has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer Fondation. Rosa Rademakers, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Kisick Family Foundation (FTD grant program). The institution of Rosa Rademakers, PhD has received research support from NIH. The institution of Rosa Rademakers, PhD has received research support from DOD. The institution of Rosa Rademakers, PhD has received research support from Flanders Institute for Biotechnology (VIB). The institution of Rosa Rademakers, PhD has received research support from Flanders Funds for Scientific Research.
Jee Hoon Roh, MD, PhD No disclosure on file
Lonni Schultz, PhD Dr. Schultz has nothing to disclose.
Marcelo Matiello, MD, FAAN Dr. Matiello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Matiello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Matiello has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for WoltersKluwer.
Audrey Strongosky No disclosure on file
Mari Tada, MD, PhD Dr. Tada has nothing to disclose.
Maria Tellez No disclosure on file
Xin Zhang No disclosure on file
Manon Bouchard, MD Dr. Bouchard has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Bouchard has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Bouchard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Es Therapeutics. Dr. Bouchard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Bouchard has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. The institution of Dr. Bouchard has received research support from FRQS. Dr. Bouchard has received publishing royalties from a publication relating to health care.
Roy Alcalay, MD Dr. Alcalay has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme/Sanofi. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gain Therapeutics. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vanqua Bio. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Capsida. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. The institution of Dr. Alcalay has received research support from Michael J. Fox Foundation. The institution of Dr. Alcalay has received research support from Parkinson's Foundation. The institution of Dr. Alcalay has received research support from Silverstein Foundation. Dr. Alcalay has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant with Parkinson's Foundation.
Stefan A. Dupont, MD, PhD No disclosure on file
Maiya Geddes, MD No disclosure on file
A. S. Girija, MD, DM No disclosure on file
Sophie Demeret Ms. Demeret has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pharmaceutical . Ms. Demeret has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pharmaceutical. Ms. Demeret has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pharmaceutical. Ms. Demeret has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmaceutical. Ms. Demeret has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmaceutical. Ms. Demeret has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmaceutical.
Kamakshi Lakshminarayan, MD, PhD Dr. Lakshminarayan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBOTT Labs. The institution of Dr. Lakshminarayan has received research support from NIH.
Youssef Dakka, MD, FAAN No disclosure on file
Nader Warra, DO No disclosure on file
Jennifer Pereira, MD Dr. Pereira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Pereira has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Pereira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Thomas Eckert, MD No disclosure on file
Eduardo Nobile-Orazio, MD, PhD, FAAN Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX, Belgium. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LFB, France. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche, Switzerland. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen, USA. The institution of Dr. Nobile-Orazio has received research support from Takeda/Shire.
Joseph S. Kass, MD, JD, FAAN Dr. Kass has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology . Dr. Kass has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Kass has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple Law Firms . Dr. Kass has received publishing royalties from a publication relating to health care.
Austen P. Moore No disclosure on file
Joung-Ho Rha, MD, PhD No disclosure on file
Mauro Zaffaroni No disclosure on file
Kevin B. Boylan, MD No disclosure on file
Ximena Arcila-Londono, MD Dr. Arcila-Londono has nothing to disclose.
Mohammad Alsharabati, MD No disclosure on file
Lesly G. Aguilar Tabora, MD No disclosure on file
Ali Bozorg, MD Dr. Bozorg has received personal compensation for serving as an employee of UCB Biosciences. Dr. Bozorg has stock in UCB.
Catherine Griffin, MD No disclosure on file
Sunil Chauhan, MD, FAAN Dr. Chauhan has nothing to disclose.
Victor Diaz-Cotrina, MD No disclosure on file
Ping-Huang Tsai, MD No disclosure on file
Jong-Ling Fuh, MD, FAAN Dr. Fuh has nothing to disclose.
Shuu-Jiun Wang, MD Dr. Wang has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli-Lilly. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Norvatis. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie. Dr. Wang has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Pfizer, Taiwan. The institution of Dr. Wang has received research support from Eli-Lilly. The institution of Dr. Wang has received research support from Norvatis.
William R. Tyor, MD, FAAN The institution of Dr. Tyor has received research support from NIH. The institution of Dr. Tyor has received research support from VHA. The institution of Dr. Tyor has received research support from NIH. The institution of Dr. Tyor has received research support from VHA. The institution of Dr. Tyor has received research support from NIH.
Khaled Anis, MD No disclosure on file
Joseph M. Ferrara, MD, FAAN No disclosure on file
Jeffrey Ralph, MD No disclosure on file
Robert B. Layzer, MD No disclosure on file
Bridget T. Carey, MD No disclosure on file
Peter Moore, MD No disclosure on file
John Pollard, MD Dr. Pollard has nothing to disclose.
Katherine A. Riester, MPH No disclosure on file
Gudarz Davar, MD No disclosure on file
Sophie Crozier No disclosure on file
David Orlikowski, MD Dr. Orlikowski has nothing to disclose.
Klaus V. Toyka, MD, FRCP, FAAN No disclosure on file
Brent P. Goodman, MD Dr. Goodman has nothing to disclose.
Ranjeeta Mani, MD No disclosure on file
Corey Goldsmith, MD, FAAN Dr. Goldsmith has received publishing royalties from a publication relating to health care.
Lori L. Billinghurst, MD Dr. Billinghurst has nothing to disclose.
Bert B. Vargas, MD, FAAN Dr. Vargas has received personal compensation for serving as an employee of Lilly USA. Dr. Vargas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Football League. Dr. Vargas has or had stock in Eli Lilly. An immediate family member of Dr. Vargas has or had stock in Pfizer.Dr. Vargas has received personal compensation in the range of $500-$4,999 for serving as a Unaffiliated Neurotrauma Consultant with National Football League. Dr. Vargas has received personal compensation in the range of $10,000-$49,999 for serving as a Neurotrauma Consultant with National Association for Stock Car Auto Racing.
Augusto A. Miravalle, MD, FAAN Dr. Miravalle has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BMS. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG therapeutics. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Miravalle has received research support from Genzyme. The institution of Dr. Miravalle has received research support from EMD Serono. The institution of Dr. Miravalle has received research support from Alexion.
James Jose, MD No disclosure on file
Charlotte Rosso No disclosure on file
Sandrine Deltour, MD No disclosure on file
Anne Leger No disclosure on file
B. L. Peterlin, DO Dr. Peterlin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for J&J. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Peterlin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan.
David S. Tabby, DO, FAAN No disclosure on file
Shinpei Yabuki No disclosure on file
Izumi Mori No disclosure on file
Yakub W. Nyandaiti, MBBS No disclosure on file
Sunday A. Bwala, MD No disclosure on file
Annette Wundes, MD, FAAN The institution of Dr. Wundes has received research support from Benaroya Research Institute .
Makoto Hirotani, MD No disclosure on file
Randall L. Woltjer Randall L. Woltjer has nothing to disclose.
Michael Katsnelson, MD No disclosure on file
Huana C. Marin, MD No disclosure on file
Do-Young Kwon No disclosure on file
Ki Y. Jung, MD No disclosure on file
Betty C. Soliven, MD Dr. Soliven has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS Pharmacy. The institution of Dr. Soliven has received research support from NIH. The institution of Dr. Soliven has received research support from NIH. The institution of Dr. Soliven has received research support from Alexion. The institution of Dr. Soliven has received research support from Roche/Genentech.
Derya Kaya No disclosure on file
Valeria Paula Fazan, MD, PhD No disclosure on file
Takafumi Hosokawa No disclosure on file
Michael Daffertshofer, MD No disclosure on file
Ivar V. Brandi, MD No disclosure on file
Martin Ballegaard, MD No disclosure on file
Smitha Suravaram No disclosure on file
Luis Fernandez No disclosure on file
Edgar De Peralta, MD No disclosure on file
Andrew Bauerschmidt, MD Dr. Bauerschmidt has nothing to disclose.
Elisabeth A. Cats, MD No disclosure on file
W.Ludo Vanderpol, MD No disclosure on file
Liat Hayardeny Nisimov, PhD No disclosure on file
Francisco Cornejo, MD No disclosure on file
Boris A. Kallmann, MD No disclosure on file
Kerstin Hellwig Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche . The institution of Kerstin Hellwig has received research support from Roche . The institution of Kerstin Hellwig has received research support from Merck . The institution of Kerstin Hellwig has received research support from Biogen. The institution of Kerstin Hellwig has received research support from Genzyme . The institution of Kerstin Hellwig has received research support from Novartis . The institution of Kerstin Hellwig has received research support from BMS .
Aki Juhani J. Hietaharju, MD, PhD No disclosure on file
Federico Serana No disclosure on file
Marco Chiarini No disclosure on file
Nayoung Kim, MD No disclosure on file
Celine Odier, MD No disclosure on file
Dang Nguyen, MD No disclosure on file
Jeffrey L. Cleland, PhD No disclosure on file
Gurjeet Singh, MD No disclosure on file
James Sheridan, PhD No disclosure on file
Valdimir Vexler No disclosure on file
Jacqueline Scena No disclosure on file
Amanda Jagolino-Cole, MD, FAAN Dr. Jagolino-Cole has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology - Neurology Clinical Practice Journal. .
Alison Green No disclosure on file
Alicia Lieberman No disclosure on file
Allison Drake No disclosure on file
Paolo Zamboni, MD No disclosure on file
Charlotte Crinquette No disclosure on file
Alexandre Mackowiak, MD No disclosure on file
Patrick Hautecoeur No disclosure on file
Veronique Miron No disclosure on file
Rebecca L. Gillani, MD The institution of Dr. Gillani has received research support from The Phyllis and Jerome Lyle Rappaport Foundation. The institution of Dr. Gillani has received research support from McCourt Foundation . The institution of Dr. Gillani has received research support from Roche.
Michael P. Macken, MD, MRCPI Dr. Macken has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharma. Dr. Macken has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Macken has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK LifeSciences. Dr. Macken has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. The institution of Dr. Macken has received research support from LivaNova.
Yoko Takiyama, MD, PhD No disclosure on file
Sung Rae Kim, MD No disclosure on file
So-Hyun Kim, MD No disclosure on file
Jeong Lee, MD No disclosure on file
Ki-Hwan Ji, MD No disclosure on file
W. O. Tobin, PhD, MBBCh, BAO, FAAN Dr. Tobin has received publishing royalties from a publication relating to health care.
Christine Pires No disclosure on file
Gauthier Calais No disclosure on file
Gurkan Mutlu, MD No disclosure on file
Errol L. Gordon, MD No disclosure on file
David Seder, MD No disclosure on file
Ovallath Thazha K. Sujith, MD Dr. Sujith has nothing to disclose.
Raj R. S. Nair, MD No disclosure on file
Douglas Bigwood No disclosure on file
Eric M. Eastman, PhD No disclosure on file
Kan Ding, MD The institution of Dr. Ding has received research support from National Institute of Aging. The institution of Dr. Ding has received research support from NINDS.
E. Ann Yeh, MD, MA, FRCPC Dr. Yeh has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pipeline therapeutics. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for SCN. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Yeh has received research support from CIHR. The institution of Dr. Yeh has received research support from National MS Society. The institution of Dr. Yeh has received research support from SickKids Foundation. The institution of Dr. Yeh has received research support from MSSC. The institution of Dr. Yeh has received research support from Garry Hurvitz Foundation. The institution of Dr. Yeh has received research support from Leong Centre. The institution of Dr. Yeh has received research support from OMSLife. The institution of Dr. Yeh has received research support from Canada's Drug Agency. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as a Author with Medscape. Dr. Yeh has a non-compensated relationship as a Editorial Board with Neurology that is relevant to AAN interests or activities. Dr. Yeh has a non-compensated relationship as a Editorial Board with MSJ that is relevant to AAN interests or activities.
Bertrand Lapergue Bertrand Lapergue has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MICROVENTION .
Violaine Denys No disclosure on file
Remy Luthringer No disclosure on file
Anthony Flint No disclosure on file
Per Djupesland No disclosure on file
Philip Seibler No disclosure on file
Katja Zschiedrich, MD No disclosure on file
Paul L. Durham, PhD No disclosure on file
Kija Weldon No disclosure on file
Niamh B. O'Hara No disclosure on file
Alfred Fonteh No disclosure on file
Tara Sharma, DO Dr. Sharma has stock in JP Morgan . Dr. Sharma has stock in Profunds.
Michael G. Harrington, MD No disclosure on file
Edward W. Brydon, PhD No disclosure on file
Mario Halfon No disclosure on file
Ruben Deogracias, PhD No disclosure on file
Galeno Rojas, MD No disclosure on file
Cinthia Farina, PhD No disclosure on file
Renato Mantegazza, MD Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Mantegazza has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Mantegazza has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SERB. The institution of Dr. Mantegazza has received research support from Alpine Immune Sciences, Inc.
Luca Massacesi The institution of Luca Massacesi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck-Serono. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson and Johnson. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Luca Massacesi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon. The institution of Luca Massacesi has received research support from Tuscan Region Government. The institution of Luca Massacesi has received research support from Sanofi. The institution of Luca Massacesi has received research support from Roche. Luca Massacesi has received research support from Merck-Serono.
Alexandra Golby No disclosure on file
Srikanth Thalakoti, MD No disclosure on file
Srikanth Damodaram, MD No disclosure on file
Ernest Balaguer, DO No disclosure on file
Antonio Callean Soto No disclosure on file
Luis Soler, MD No disclosure on file
David Bradley, MD Dr. Bradley has nothing to disclose.
Ronald O. Bailey, MD No disclosure on file
Julia Gasch No disclosure on file
Katja Thomas, MD No disclosure on file
Tanja D. Kuhlmann, MD No disclosure on file
Julie Munakata No disclosure on file
Ningshan Wang, MD, PhD Dr. Wang has nothing to disclose.
Avi A. Algom, MD No disclosure on file
Roisin Lonergan, MD No disclosure on file
Cristina Duran No disclosure on file
Katherine Schweitzer, MD No disclosure on file
Anne Waschbisch No disclosure on file
Dorothea A. Buck, MD No disclosure on file
Dan Hesse No disclosure on file
David E. Anderson No disclosure on file
Derek Narendra, MD The institution of Dr. Narendra has received research support from National Institutes of Health.
Michael Hecker, PhD No disclosure on file
Brian Sweeney, MD No disclosure on file
Katie Doyle No disclosure on file
Sinead Jordan Sinead Jordan has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen Idec. Sinead Jordan has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen Idec. Sinead Jordan has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Sinead Jordan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Sinead Jordan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen Idec.
Raquel Gardner, MD Dr. Gardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BrainBox. The institution of Dr. Gardner has received research support from NIH. The institution of Dr. Gardner has received research support from DoD.
Eric Tsang No disclosure on file
Karen Lane No disclosure on file
Jennifer Madan Cohen, MD No disclosure on file
Reynaldo Mustelier No disclosure on file
Marcelo Cruzeiro, MD No disclosure on file
Camila Pupe, MD Dr. Pupe has nothing to disclose.
David Dolezil, MD No disclosure on file
Sung-Min Kim, MD No disclosure on file
Christopher S. Nance, MD No disclosure on file
Muhammad Ibrahimi, MD No disclosure on file
Neil Manus No disclosure on file
Rebecca Ayala No disclosure on file
Shelley Redfern No disclosure on file
Angela McNamara No disclosure on file
Karl Krecke Karl Krecke has nothing to disclose.
Ying-Fa Chen, MD No disclosure on file
Minsyu Lan No disclosure on file
Yung-Yee Chang No disclosure on file
Jia S. Liu, MD No disclosure on file
Jason Martin No disclosure on file
Bram Jacobs, MD No disclosure on file
Pieter E. Vos, MD, PhD No disclosure on file
Fabio M. Iwamoto, MD No disclosure on file
Kitti Kaiboriboon, MD No disclosure on file
Michael Chilungu, MD No disclosure on file
Steven Moore, PhD No disclosure on file
Babak Movassaghi, MD No disclosure on file
Frasat Chaudhry, MD Dr. Chaudhry has nothing to disclose.
Elena Bravver, MD No disclosure on file
Sylvia R. Delgado, MD, FAAN The institution of Dr. Delgado has received research support from Novartis. The institution of Dr. Delgado has received research support from EMD Serono.
Sara El Alaoui No disclosure on file
Rebecca E. Matthews, MD Dr. Matthews has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Penry Epilepsy Programs.
Hong Jiang, MD, PhD The institution of Dr. Jiang has received research support from Florida Health. The institution of Dr. Jiang has received research support from NINDS RO1.
Aurelio Mendez-Dominguez, MD Dr. Mendez-Dominguez has nothing to disclose.
Jay Shah, MD Dr. Shah has nothing to disclose.
Craig Carroll, DO No disclosure on file
Lori Chibnik No disclosure on file
Khosro Farhad, MD, FAAN Dr. Farhad has nothing to disclose.
Benjamin P. George, MD Dr. George has nothing to disclose.
Pearce J. Korb, MD, FAAN Dr. Korb has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical Education Resources.
Juan A. Ollari, MD, FAAN No disclosure on file
Michael Phipps, MD, MHS, FAAN Dr. Phipps has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMJ.
Marvin S. Sih, MD No disclosure on file
Eoin P. Flanagan, MBBCh, FAAN The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Merck. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology that is relevant to AAN interests or activities.
Vibhav K. Bansal, MD, JD No disclosure on file
Navid Seraji-Bozorgzad, MD No disclosure on file
Mohamed Kazamel, MD Dr. Kazamel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam Pharamceuticals. Dr. Kazamel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea Therapeutics.
Kimberly Robeson, MD, FAAN Dr. Robeson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Robeson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion.
Ezequiel A. Piccione, MD, FAAN Dr. Piccione has nothing to disclose.
Sunil Mutgi, MD No disclosure on file
Ariel Antezana, MD Dr. Antezana has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Antezana has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Antezana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Antezana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Dr. Antezana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Peter S. Pressman, MD Dr. Pressman has received personal compensation in the range of $100,000-$499,999 for serving as a Associate Professor with University of Colorado School of Medicine.
Cindy L. Jadoo, MD No disclosure on file
Daniel DiCapua, MD, FAAN Dr. DiCapua has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. DiCapua has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx.
Andre P. Matta, MD Dr. Matta has received personal compensation for serving as an employee of Sanofi. Dr. Matta has received stock or an ownership interest from Sanofi.
Ricky Lee, MD No disclosure on file
Ramon Lugo, MD No disclosure on file
Jacquelyne Kane, MD No disclosure on file
Alan Wang, MD, FAAN Dr. Wang has stock in AbbVie.
Prityi Rani, MD No disclosure on file
Carolyn Cronin, MD, PhD, FAAN Dr. Cronin has nothing to disclose.
Collin H. York No disclosure on file
Chirantan Banerjee, MD, MPH Dr. Banerjee has nothing to disclose.
Joseph C. Alario, DO Dr. Alario has nothing to disclose.
Vamshi Balasetti, MD No disclosure on file
Kateryna Kurako, MD Dr. Kurako has nothing to disclose.
Ryo Ohtomo, MD No disclosure on file
Carmen Serrano, MD, FAAN The institution of Dr. Serrano has received research support from Eli Lilly. The institution of Dr. Serrano has received research support from Abbvie.
Scott E. Cooper, MD, PhD The institution of Dr. Cooper has received research support from NIH.
Michal T. Gostkowski, DO The institution of Dr. Gostkowski has received research support from Medtronic.
Fermina A. Pirmohamed, MD No disclosure on file
Hesham A. Abboud, MD Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech . Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpine Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cycle Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axonics. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Abboud has received research support from Genentech . The institution of Dr. Abboud has received research support from Novartis. The institution of Dr. Abboud has received research support from BMS. The institution of Dr. Abboud has received research support from Sanofi-Genzyme. The institution of Dr. Abboud has received research support from The Guthy-Jackson Charitable Foundation. The institution of Dr. Abboud has received research support from UCB. Dr. Abboud has received publishing royalties from a publication relating to health care.
Bernadette Nazario-Lopez, MD No disclosure on file
Shaheryar Hafeez, MD Dr. Hafeez has nothing to disclose.
Pedro W. Vivar Cruz, MD No disclosure on file
Channaiah Srikanth Mysore No disclosure on file
Alexis B. Shaefer, MD Dr. Shaefer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Shaefer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Takeda. Dr. Shaefer has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Takeda. Dr. Shaefer has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Law firms.
Giorgia Querin, MD No disclosure on file
Gianni Soraru No disclosure on file
Ignacio Demey, MD, PhD Ignacio Demey, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Laboratorio Bagó.
Kathleen Sullivan No disclosure on file
Caroline B. Braune, MD Dr. Braune has nothing to disclose.
Edoardo G. Spinelli, MD Dr. Spinelli has nothing to disclose.
Gencer Genc, MD Dr. Genc has nothing to disclose.
Masoud Majed, MD Dr. Majed has nothing to disclose.
Stephanie Grover, MSc, CCRP No disclosure on file
Steven Xian, MD No disclosure on file
Caroline Arquizan No disclosure on file
Irving M. Asher, MD No disclosure on file
Christopher S. Williams, DO, MPH No disclosure on file
Laurie McWilliams-Dunnigan, MD No disclosure on file
Ho-Yann Jong, MD No disclosure on file
Jules Osias, MD No disclosure on file
Jeffrey B. Hainsworth, DO Dr. Hainsworth has stock in Amgen Inc. Dr. Hainsworth has stock in Bristol Myers Squibb Company. Dr. Hainsworth has stock in Johnson & Johnson. Dr. Hainsworth has stock in Medtronic PLC. Dr. Hainsworth has stock in Merck. Dr. Hainsworth has stock in Stryker Corp. Dr. Hainsworth has stock in ABBV.
Michael V. Mendoza, MD No disclosure on file
Oscar Martinez, MD No disclosure on file
JESSIE K. GREWAL, MD No disclosure on file
Henrik Wilms, MD, PhD Henrik Wilms, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TEVA.
Marcela Uribe Roca The institution of Marcela Uribe Roca has received research support from Roche.
Alicia Zha, MD The institution of Dr. Zha has received research support from American Academy of Neurology. The institution of Dr. Zha has received research support from American Board of Psychiatry and Neurology.
Rodica Di Lorenzo, MD Dr. Di Lorenzo has nothing to disclose.
Pei'En Fan, MD No disclosure on file
Zain Guduru, MD, FAAN Dr. Guduru has nothing to disclose.
Allyson Bazarsky, DO No disclosure on file
Nicki Niemann, MD No disclosure on file
Umair Afzal, MBBS No disclosure on file
Tamara B. Kaplan, MD, FAAN Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono . Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen.
Derek T. Soon, MBBS, PhD Dr. Soon has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Legal Clinic.
Aman Deep, MD Dr. Deep has nothing to disclose.
Ligia R. Andrade, MD No disclosure on file
Mariane D. Barbosa, MD Dr. Barbosa has nothing to disclose.
Lilian R. Corade, MD No disclosure on file
Kalliopi Pitarokoili, MD Dr. Pitarokoili has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring.
Cecilia Vidal, MD No disclosure on file
Lauren Davis No disclosure on file
Lisena Hasanaj Ms. Hasanaj has nothing to disclose.
John-Ross Rizzo No disclosure on file
Brandi L. Vollmer, MPH Ms. Vollmer has nothing to disclose.
Maria S. Pacha No disclosure on file
Fatima Pantiu No disclosure on file
Joana C. Dias, MD No disclosure on file
Carolyn Sawicki No disclosure on file
Melanie Wegener No disclosure on file
Ani Mnatsakanian No disclosure on file
Edison K. Miyawaki, MD Dr. Miyawaki has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Family Health, Inc.. Dr. Miyawaki has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Morrison and Mahoney. Dr. Miyawaki has stock in Cincinnati Bengals. Dr. Miyawaki has received publishing royalties from a publication relating to health care. Dr. Miyawaki has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with US Department of Health and Human Services.
Angala B. Borders-Robinson, DO No disclosure on file
Aamrarif D. Herekar, MD No disclosure on file
William G. Buxton, MD Dr. Buxton has nothing to disclose.
Hos C. Loftus, MD No disclosure on file
William Anderson No disclosure on file
Saulena S. Shafer, DO No disclosure on file
Timothy Leichliter, MD Dr. Leichliter has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine.
Quynh Vo, MD Dr. Vo has nothing to disclose.
Trevor Hawkins, MD Dr. Hawkins has nothing to disclose.
Michael J. Persenaire, MD Dr. Persenaire has nothing to disclose.
Hyun-Sik Yang, MD Dr. Yang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axon advisors. The institution of Dr. Yang has received research support from National Institutes of Health. Dr. Yang has received personal compensation in the range of $500-$4,999 for serving as a study section member with National Institutes of Health.
Eric D. Prince, MD No disclosure on file
James Fryer James Fryer has received intellectual property interests from a discovery or technology relating to health care.
Karina L. Pires, MD Dr. Pires has nothing to disclose.
Henrique D. Rodrigues Cal, MD Dr. Rodrigues Cal has nothing to disclose.
Luca Bello Mr. Bello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Mr. Bello has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edgewise Therapeutics. Mr. Bello has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Mr. Bello has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for PTC Therapeutics.
Jessica A. Sagen, MA Ms. Sagen has nothing to disclose.
Helen Hwang, MD Dr. Hwang has nothing to disclose.
Luciana V. Leon Cejas, MD Dr. Leon Cejas has nothing to disclose.
Debora Szklarz, MD No disclosure on file
Jonathan Urrego Jonathan Urrego has nothing to disclose.
Jessica Lowe, MD No disclosure on file
Muhammad Athar Muhammad Athar has nothing to disclose.
Stefan Sillau Stefan Sillau has nothing to disclose.